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1. INTRODUCTION
1.1 HERBS
Herbs are staging a comeback and herbal ‘renaissance’ is happening all over
the globe. The herbal products today symbolise safety in contrast to the synthetics
that are regarded as unsafe to human and environment. Although herbs had been
priced for their medicinal, flavoring and aromatic qualities for centuries, the
synthetic products of the modern age surpassed their importance, for a while.
However, the blind dependence on synthetics is over and people are returning to the
naturals with hope of safety and security. Over three-quarters of the world
population relies mainly on plants and plant extract for health care. More than 30%
of the entire plant species, at one time or other were used for medicinal purposes.
Human being appears to be afflicted with diseases more than any other
animal species. Thus he very early sought to alleviate his sufferings from injury and
disease by taking advantage of plants around him. Today a vast store of knowledge
concerning therapeutic properties of different plants has amassed. All phyla of plants
contain species that yield official and unofficial products of medicinal importance.
By far the greatest number of these are derived from plants (Kokate C.K., 1995).
In India, drugs of herbal origin have been used in traditional systems of
medicines such as Unani and Ayurved since ancient times. The Ayurveda system of
medicine uses about 700 species, Unani 700, Siddha 600, Amchi 600 and modern
medicine around 30 species. The drugs are derived either from the whole plant or
from different organs, like leaves, stem, bark, root, flower, seed, etc. Some drugs are
prepared from excretory plant product such as gum, resins and latex. Even the
Allopathic system of medicine has adopted a number of plant-derived drugs which
form an important segment of the modern pharmacopoeia. Some important chemical
intermediates needed for manufacturing the modern drugs are also obtained from
plants (Eg. diosgenin, solasodine, b-ionone). Not only, that plant-derived drug offers
a stable market worldwide, but also plants continue to be an, important source for
new drugs.
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Traditional systems of medicine continue to be widely practiced on many
accounts. Population rise, inadequate supply of drugs, prohibitive cost of treatments,
side effects of several allopathic drugs and development of resistance to currently
used drugs for infectious diseases have led to increased emphasis on the use of plant
materials as a source of medicines for a wide variety of human ailments.
Ayurveda, Siddha, Unani and Folk (tribal) medicines are the major systems
of indigenous medicines. Among these systems, Ayurveda is most developed and
widely practiced in India. Ayurveda dating back to 1500-800 BC has been an
integral part of Indian culture. The term comes from the Sanskrit root Au (life) and
Veda (knowledge). As the name implies it is not only the science of treatment of the
ill but covers the whole gamut of happy human life involving the physical,
metaphysical and the spiritual aspects. Ayurveda recognises that besides a balance
of body elements one has to have an enlightened state of consciousness, sense
organs and mind if one has to be perfectly healthy. Ayurveda by and large is an
experience with nature and unlike in Western medicine, many of the concepts elude
scientific explanation. Ayurveda is gaining prominence as the natural system of
health care all over the world. Today this system of medicine is being practiced in
countries like Nepal, Bhutan, Sri Lanka, Bangladesh and Pakistan, while the
traditional system of medicine in the other countries like Tibet, Mongolia and
Thailand appear to be derived from Ayurveda.
Phytomedicines are also being used increasingly in Western Europe.
Recently the US Government has established the “Office of Alternative Medicine”
at the National Institute of ealth at Bethesda and its support to alternative medicine
includes basic and applied research in traditional systems of medicines such as
Chinese, Ayurvedic, etc. with a view to assess the possible integration of effective
treatments with modern medicines. The development of systematic pharmacopoeias
dates back to 3000 BC, when the Chinese were already using over 350 herbal
remedies. Ayurveda, a system of herbal medicine in India, Sri Lanka and South-East
Asia has more than 8000 plant remedies and using around 35,000-70,000 plant
species. China has demonstrated the best use of traditional medicine in providing the
health care. China has pharmacologically validated and improved many traditional
herbal medicines and eventually integrated them in formal health care system.
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Green plants synthesise and preserve a variety of biochemical products,
many of which are extractable and used as chemical feed stocks or as raw material
for various scientific investigations. Many secondary metabolites of plant are
commercially important and find use in a number of pharmaceutical compounds.
However, a sustained supply of the source material often becomes difficult due to
the factors like environmental changes, cultural practices, diverse geographical
distribution, labour cost, and selection of the superior plant stock and over
exploitation by pharmaceutical industry.
Plants, especially used in Ayurveda can provide biologically active
molecules and lead structures for the development of modified derivatives with
enhanced activity and /or reduced toxicity. The small fraction of flowering plants
that have so far been investigated have yielded about 120 therapeutic agents of
known structure from about 90 species of plants. Some of the useful plant drugs
include vinblastine, vincristine, taxol, podophyllotoxin, camptothecin, digitoxigenin,
gitoxigenin, digoxigenin, tubocurarine, morphine, codeine, aspirin, atropine,
pilocarpine, capscicine, allicin, curcumin, artemesinin and ephedrine among others.
In some cases, the crude extract of medicinal plants may be used as medicaments.
On the other hand, the isolation and identification of the active principles and
elucidation of the mechanism of action of a drug is of paramount importance. Hence,
works in both mixture of traditional medicine and single active compounds are very
important. Where the active molecule cannot be synthesised economically, the
product must be obtained from the cultivation of plant material. About 121 (45
tropical and 76 subtropical) major plant drugs have been identified for which no
synthetic one is currently available (table 1). The scientific study of traditional
medicines, derivation of drugs through bioprospecting and systematic conservation
of the concerned medicinal plants are thus of great importance.
The history of medicines is as old as human civilization. The documents
reveal that plants were used medicinally in India, china, Egypt and Greece long
before the beginning of the Christian era. One of the most famous surviving
remnants is the Papyrus Beers. The text of document is dominated by more than 800
formulae and 700 different drugs. Most of the medicinally active substances
identified in the nineteenth and twentieth century were used in the form of crude
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extract. Indians also worked to examine and classify the herbs which they came
across, into groups called Guans. Charaka made 50 groups of ten herbs each of
which would suffice an ordinary physician’s need. Similarly Sushruta arranged 760
herbs in 7 different sets based on some of their common properties. A large portion
of the Indian population even today depends on the Indian system of medicine-
Ayurveda (Gratus et al., 2009).
Table 1. Major plant drugs for which no synthetic one is currently available (Kumar
et al, 1997).
Drug Plant Use
Vinblastine
Ajmalacine
Rescinnamine
Reserpine
Quinine
Pilocarpine
Cocaine
Morphine
Codeine
Atropine
Atropine
Cardiacglycosides
.
Artemisinin
Taxol
Berberine
Catharanthus roseus
Catharanthus roseus
Rauvolfia serpentine
Rauvolfia serpentine
Cinchona sp.
Pilocarpus jaborandi
Erythroxylum coca
Papaver somniferum
Papaver somniferum
Atropa belladonna
Hyoscyamus niger
Digitalis sp
Artemesia annua
T. brevifolia
Taxus baccata
Berberis
Anticancer
Anticancer, hypotensive
Tranquilizer
Tranquilizer
Antimalarial,amoebic
dysentery
Antiglucoma
Topical anesthetic
Painkiller
Spasmolytic, cold
Spasmolytic, cold
For congestive heart
Failure
Antimalarial,
Breast and ovary cancer ,
antitumour
For leishmaniasis
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Diospyrin
Gossypol
Allicin
Ricin
Glycyrrhizin
Nimbidin
Catechin
Sophoradin
Magnolol
Forskolin
Digitoxin,Digoxin
Thevenerin,
Nerrifolin
Podophyllin
IndicineN-oxide
Elipticine
Homoharringtonine
Camptothecine
Diospyros Montana
Gossypium sp.
Allium sativum
Ricinus communis
Cephaelis ipecacuanha
Glycyrrhizia glabra
Azadirachta indica
Acacia catechu
Sophora subprostrata
Magnolia bark
Coleus forskohlii
Digitalis, Thevetia
Thevetia
Thevetia
Podophyllum emodi
Heliotropium indicum
Ochrosia
Cephalotaxus
Camptotheca acuminate
Antibacterial, antifungal
Antispermatogenic
Antifungal, amoebiasis
Emetine
Amoebiasis
Antiulcer
Antiulcer
Antiulcer
Antiulcer
Peptic ulcer
Hypotensive, cardiotonic
Cardio tonic
Cardio tonic
Cardio tonic
Anticancer
Anticancer
Anticancer
Anticancer
Anticancer
A major lacuna in Ayurveda is the lack of drug standardisation, information
and quality control. Most of the Ayurvedic medicines are in the form of crude
extracts which are a mixture of several ingredients and the active principles when
isolated individually fail to give desired activity. This implies that the activity of the
extract is the synergistic effect of its various components. In the absence of
pharmacopoeia data on the various plant extracts, it is not possible to isolate or
standardise the active contents having the desired effects. Ayurvedic pharmacopoeia
compiled on modern lines and updated periodically is an urgent requirement.
A combination therapy integrating Ayurveda and allopathy whereby the side
effects and undesirable reactions could be controlled can be thought of. Studies can
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show that the toxic effects of radiations and chemotherapy in cancer treatment could
be reduced by Ayurvedic medications and similarly surgical wound healing could be
accelerated by Ayurvedic medicines. Modern science and technology have an
essential role to play in the process. An integrated approach for the cultivation,
conservation and preservation of important plant species through plant molecular
biology, plant tissue culture; research on the rationale and methodology of
Ayurvedic medical practice; isolation of active constituents and their development
into new therapeutics; standardisation and validation of known herbal medicines
and other related aspects need to be focused upon (Sharma, 1997).
Despite the diverse nature of crops grown in the country and the existence of
a fast-growing pharmaceutical sector, the share of India in world trade is quite
insignificant considering the large geographical area. However, this is bound to rise
rapidly with better research inputs and efficient management of the farm sector. So
far, India has been involved in the export of only large volume raw material. To
achieve competitive advantage we need to resort to low volume high cost (value)
trade through value addition to the raw and unfinished products. It is therefore,
necessary to develop genetically superior planting material for assured uniformity
and desired quality and resort to organized cultivation to ensure the supply of raw
material at grower’s end. Post harvest storage and process technologies need to be
developed to produce the value added finished products that may be directly utilised
by the industry
Inventorisation of herbal drugs used in traditional and modern medicines for
acountry like India, appears to be a stupendous task, where a number of well
established indigenous or traditional systems, including Ayurveda, Unani, Siddha,
Homoeopathy, Tibetan, Amchi, Yoga and Naturopathy are practised along with
modern medicine for the management of total health care system. In all these
systems a large number of plant drugs are used, although there may be some
common plants. Another problem in correct identification of plants is that the plant
drugs in those systems of medicine are known by their classical, Shastriya or
vernacular names. It is not easy to correlate these names with acceptable scientific
names. One plant species can have many vernacular classical names and one name
may refer to different plant species. Chinese, Indian, Arabian and other traditional
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systems of medicines make extensive use of about 5000 plants. India is proud to be
rich in biological diversity and tenth among the plant rich countries of Asia, sixth as
far as centres of diversity especially agrodiversity are concerned. Nearly three
fourth of the drugs and perfumery products used in the world are available in natural
state in the country. India possesses almost 8% of the estimated biodiversity of the
world with around 1, 26,000 species. It is one of the 12 mega biodiversity centres
with 2 hot spots of biodiversity in western Ghats and north-eastern region.
The sacred groves are a miniature ecosystem conserving biodiversity in its
pristine form. There are about 400 families in the world of flowering plants; at least
315 are represented in India. According to WHO, around 21,000 plant species have
the potential for being used as medicinal plants? About 5000 species have been
studied. There are at least 121 major plant drugs of known structure, but synthetic
means. For developing phytomedicines as a major area of concern, it would be
essential to adopt a holistic interdisciplinary approach, have a scientific basis of the
understanding of the plant systems, new innovations and their conservation for
utilization in future on a sustainable basis (Sharma, 1997).
 Plant species with therapeutic value under different plant groups(Jiaxiang,
1997).
Halophytes 230
Bryophytes 39
Pteridophytes 382
Gymnospermae 55
Angiospermae:
A)Monocotyledones 676
b) Dicotyledones 3495
Total 4877
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Table No. 2. List of Anti-ulcer plants
Plant Family Plant part used
Alpinia allughas Zingiberaceae Rhizome
Alpinia galangal Zingiberaceae Rhizome
Alpinia calcarata Zingiberaceae Rhizome
Glycyrrhiza glabra Liquorice Stem, root
Azadirachta indica Meliaceae Bark, leaves, flower
Acacia catechu Mimosaceae Bark
Sophora subprostrata Leguminaceae Root
Magnolia bark Magnoliaceae Bark
Gloriosa superb Liliaceae Roots, rhizome
Phyllanthus emblica Euphorbiaceae Root, bark
Aegle marmelos Rutaceae Leaf
Indigofera tinctoria Papillonaceae Leaf, fruit
Pongamia pinnata Papillonaceae Whole plant
Eclipta prostate Asteraceae Root
Terminalia arjuna Combretaceae Bark
Terminalia alata Combretaceae Bark
Terminalia chebula Combretaceae Powdered fruit
Coleus vettiveroides Lamiaceae Whole plant
Punia granatum Puniaceae Fruit
Murraya koenigii Rutaceae Leaf
Solanum melongina Solanaceae Fruit
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Solanum nigram Solanaceae Plant
Bauhinia variegate Caesalpiniaceae Bark
Bauhinia purpurea Caesalpiniaceae Bark
Gymnema sylvestre Asclepiadaceae Whole plant
Balospermum
montanum
Euphorbiaceae Root
Saraca asoca Caesalpiniaceae Bark
Andrographis paniculata Acanthaceae Whole plant
Aristolochia bracteolata Aristolochiaceae Whole plant
Ficus microcarpa Moraceae Bark, leaf
Mimusops elengi Sapotaceae Flower
Lagenaria vulgaris Curcubitaceae Fruit
Mormodica charatia Curcubitaceae Fruit, seed
Citrullus colocynthis Curcubitaceae Fruit, root
The modern life style in terms of food, daily working pressure and use of
medicine for common causes has been increased. All three has impact on GIT
(gastrointestinal tract) causes many problem, one of them is gastric ulcer. It is an
open discontinuation on the mucous membrane causes pain and usually inflamed
called peptic ulcer.
The two most common types of peptic ulcer are called “gastric ulcers” and
“duodenal ulcers”. These names refer to the location where the ulcer is found.
Gastric ulcers are located in the stomach. Duodenal ulcers are found at the beginning
of the small intestine known as the duodenum. A person may have both gastric and
duodenal ulcers at the same time. People infected with H. pylori are at increased
risk of developing peptic ulcers. When a person is diagnosed with an ulcer, testing
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for H. pylori is often done. There are a number of tests to diagnose H. pylori. Which
test is used depends on the situation.
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) are a group of
medications typically used to treat pain.  People, who take NSAIDs for a long time,
at high doses or both, have a higher risk of developing ulcers. 5 - 10% of the world’s
population suffers at least once in their life from a peptic ulcer. Infection with H.
pylori is the major cause of peptic ulcer disease and also a risk factor for cancer of
the stomach.
It is well established that diet rich in vegetables and fruits can reduce
disturbances in gastrointestinal system. Moreover, large number of populations
today uses herbal therapies and home remedies along with conventional
medications. However, concurrent use of these remedies with modern medications
may cause either potentially dangerous side effects or enhanced therapeutic efficacy.
In traditional medicine, several plants and herbs have been used to treat
gastrointestinal disorders, including gastric ulcers. The first drug effective against
gastric ulcer was carbenoxolone, discovered as a result of research on a commonly
used indigenous plant, Glycyrrhiza glabra. Studies on cabbage previously employed
as an antiulcer agent in folk medicine, which acts by enhancing the gastric mucosal
strength. Banana fruit has also been found to inhibit peptic ulceration. It is  reported
the antiulcer activity of species of the Campanulaceae in experimental models, while
Kanturek et al found solon, a flavonoid, to be effective against ulcer in experimental
animals. Meliaazedarach has been observed to inhibit stress-induced ulcer in rats.
Santalum album stem is also used as an anti ulcer agent in traditional medicine
1.2 PEPTIC ULCER
The acid-peptic diseases are those disorders in which gastric acid and pepsin
are necessary, but usually not sufficient, pathogenic factors. While inherently
caustic, acid and pepsin in the stomach normally do not produce damage or
symptoms because of intrinsic defense mechanisms. Barriers to the reflux of gastric
contents into the esophagus comprise the primary esophageal defense. Peptic ulcers
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are craters or open sores in the lining of the upper gastrointestinal tract (GIT). They
include duodenal ulcers (those that are located in the top of the small intestine or
duodenum) and gastric ulcers (those found in the stomach). Peptic ulcers are
common and usually occur singly. But it is possible to have two or more, or even
both duodenal and gastric ulcers at the same time.
Although the pathogenesis of peptic ulcer disease is not fully understood,
three major factors are recognized: infection with gram-negative H. pylori, increased
hydrochloric acid secretion, and inadequate mucosal defense against gastric acid.
Treatment approaches include (1) eradicating H. pylori infection, (2) reducing
secretion of gastric acid or neutralizing the acid after it is released, and (3) providing
agents that protect the gastric mucosa from damage
.
Digestive system: Cross-section of the alimentary tube has four layers the mucosa,
submucosa, external muscle layer, and serosa. Each layer has a speciﬁc structure,
and its functions contribute to the functioning of the organs of which it is a part.
Esophagus: The esophagus is a muscular tube that takes food from the pharynx to
the stomach. No digestion takes place here. Peristalsis of the esophagus propels food
in one direction and ensures that food gets to the stomach even if the body is
horizontal or upside down. At the junction with the stomach, the lumen (cavity) of
the esophagus is surrounded by the lower esophageal sphincter (LES or cardiac
sphincter), a circular smooth muscle. The LES relaxes to permit food to enter the
stomach, and then contracts to prevent the backup of stomach contents. If the LES
does not close completely, gastric juice may splash up into the esophagus this is a
painful condition we call heartburn, or gastroesophageal reﬂux disease (GERD).
Most people experience heartburn once in a while, and it is merely uncomfortable,
but chronic GERD is more serious. The lining of the esophagus cannot withstand the
corrosive action of gastric acid and will be damaged, perhaps resulting in bleeding
or even perforation. Medications are available to treat this condition.
MUCOSA: The mucosa, or lining, of the alimentary tube is made of
epithelial tissue, areolar connective tissue, and two thin layers of smooth muscle. In
the esophagus the epithelium is stratiﬁed squamous epithelium; in the stomach and
intestines it is simple columnar epithelium. The epithelium secretes mucus, which
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lubricates the passage of food, and also secretes the digestive enzymes of the
stomach and small intestine. Just below the epithelium, within the areolar connective
tissue, are lymph nodules that contain lymphocytes to produce antibodies, and
macrophages to phagocytize bacteria or other foreign material that get through the
epithelium. The thin layers of smooth muscle create folds in the mucosa, and ripples,
so that all of the epithelial cells are in touch with the contents of the organ. In the
stomach and small intestine this is important for absorption.
SUBMUCOSA: The submucosa is made of areolar connective tissue with
many blood vessels and lymphatic vessels. Many millions of nerve ﬁbers are also
present, part of what is called the enteric nervous system, or the “brain of the gut,”
which extends the entire length of the alimentary tube. The nerve networks in the
submucosa are called Meissner’s plexus (or submucosal plexus) and they innervate
the mucosa to regulate secretions.Parasympathetic impulses increase secretions,
whereas sympathetic impulses decrease secretions. Sensory neurons are also present
to the smooth muscle (a stretched or cramping gut is painful), as are motor neurons
to blood vessels, to regulate vessel diameter and blood ﬂow.
SEROSA :  Above the diaphragm, for the esophagus, the serosa, the
outermost layer, is ﬁbrous connective tissue. Below the diaphragm, the serosa is the
mesentery or visceral peritoneum, a serous membrane. Lining the abdominal cavity
is the parietal peritoneum, usually simply called the peritoneum. The peritoneum-
mesentery is actually one continuous membrane.
The serous ﬂuid between the peritoneum and mesentery prevents friction when the
alimentary tube contracts and the organs slide against one another. The preceding
descriptions are typical of the layers of the alimentary tube. As noted, variations are
possible, and any important differences are mentioned in the sections that follow on
speciﬁc organs.
STOMACH: The stomach is located in the upper left quadrant of the
abdominal cavity, to the left of the liver and in front of the spleen. Although part of
the alimentary tube, the stomach is not a tube, but rather a sac that extends from the
esophagus to the small intestine. Because it is a sac, the stomach is a reservoir for
food, so that digestion proceeds gradually and we do not have to eat constantly. Both
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mechanical and chemical digestion takes place in the stomach. The parts of the
stomach are shown in Fig 1. The cardiac oriﬁce is the opening of the esophagus, and
the fundus is the portion above the level of this opening. The body of the stomach is
the large central portion, bounded laterally by the greater curvature and medially by
the lesser curvature. The pylorus is adjacent to the duodenum of the small intestine,
and the pyloric sphincter surrounds the junction of the two organs. The fundus and
body are mainly storage areas, whereas most digestion takes place in the pylorus.
When the stomach is empty, the mucosa appears wrinkled or folded. These folds are
called rugae; they ﬂatten out as the stomach is ﬁlled and permit expansion of the
lining without tearing it. The gastric pits are the glands of the stomach and consist of
several types of cells; their collective secretions are called gastric juice. Mucous
cells secrete mucus, which coats the stomach lining and helps prevent erosion by the
gastric juice. Chief cells secrete pepsinogen, an inactive form of the enzyme pepsin.
Parietal cells produce hydrochloric acid (HCl); these cells have enzymes called
proton pumps, which secrete H+ ions into the stomach cavity. The H ions unite with
Cl- ions that have diffused from the parietal cells to form HCl in the lumen of the
stomach. HCl converts pepsinogen to pepsin, which then begins the digestion of
proteins to polypeptides, and also gives gastric juice its PH of 1 to 2. This very acidic
PH is necessary for pepsin to function and also kills most microorganisms that enter
the stomach. The parietal cells also secrete intrinsic factor, which is necessary for
the absorption of vitamin B12. Enteroendocrine cells called G cells secrete the
hormone gastrin. Gastric juice is secreted in small amounts at the sight or smell of
food. This is a parasympathetic response that ensures that some gastric juice will be
present in the stomach when food arrives. The presence of food in the stomach
causes the G cells to secrete gastrin, a hormone that stimulates the secretion of
greater amounts of gastric juice.
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Fig: 01: Stomach anterior view and gastric pits
The external muscle layer of the stomach consists of three layers of smooth
muscle circular, longitudinal, and oblique layers. These three layers are innervated
by the enteric plexuses of the enteric nervous system. Stimulatory impulses are
carried from the CNS by the vagus nerves (10th cranial) and provide for very
efficient mechanical digestion to change food into a thick liquid called chyme. The
pyloric sphincter is usually contract when the stomach is churning food; it relaxes at
intervals to permit small amounts of chyme to pass into the duodenum. This
sphincter then contracts again to prevent the back up of intestinal contents into the
stomach.
Regulation of Pepsinogen Secretion
Regulation of pepsinogen secretion by the peptic cells in the oxyntic glands
is much less complex than regulation of acid secretion; it occurs in response to two
types of signals: (1) stimulation of the peptic cells by acetylcholine released from the
vagus nerves or from the gastric enteric nervous plexus, and (2) stimulation of peptic
cell secretion in response to acid in the stomach. The acid probably does not
stimulate the peptic cells directly but instead elicits additional enteric nervous
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reﬂexes that support the original nervous signals to the peptic cells. Therefore, the
rate of secretion of pepsinogen, the precursor of the enzyme pepsin that causes
protein digestion, is strongly inﬂuenced by the amount of acid in the stomach. In
people who have lost the ability to secrete normal amounts of acid, secretion of
pepsinogen is also decreased, even though the peptic cells may otherwise appear to
be normal.
History
John Lykoudis, a general practitioner in Greece, treated patients for peptic
ulcer disease with antibiotics, beginning in 1958, long before it was commonly
recognized that bacteria were a dominant cause for the disease.
Helicobacter pylori was rediscovered in 1982 by two Australian scientists,
Robin Warren and Barry J. Marshall as a causative factor for ulcers. In their original
paper, Warren and Marshall contended that most stomach ulcers and gastritis were
caused by colonization with this bacterium, not by stress or spicy food as had been
assumed before.
The H. pylori hypothesis was poorly received, so in an act of self-
experimentation Marshall drank a Petri dish containing a culture of organisms
extracted from a patient and soon developed gastritis. His symptoms disappeared
after two weeks, but he took antibiotics to kill the remaining bacteria at the urging of
his wife, since halitosis is one of the symptoms of infection. This experiment was
published in 1984 in the Australian Medical Journal and is among the most cited
articles from the journal.
In 1997, the Centers for Disease Control and Prevention, with other
government agencies, academic institutions, and industry, launched a national
education campaign to inform health care providers and consumers about the link
between H. pylori and ulcers. This campaign reinforced the news that ulcers are a
curable infection, and that health can be greatly improved and money saved by
disseminating information about H. pylori.
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In 2005, the Karolinska Institute in Stockholm awarded the Nobel Prize in
Physiology or Medicine to Dr. Marshall and his long-time collaborator Dr. Warren
"for their discovery of the bacterium Helicobacter pylori and its role in gastritis and
peptic ulcer disease". Professor Marshall continues research related to H. pylori and
runs a molecular biology lab at UWA in Perth, Western Australia.It was a previously
widely accepted misunderstanding that the use of chewing gum resulted in gastric
ulcers. The medical profession believed that this was because the action of
masticating on gum caused the over-stimulation of the production of hydrochloric
acid in the stomach. The low (acidic) PH (PH 2), or hyperchlorhydria was then
believed to cause erosion of the stomach lining in the absence of food, thus causing
the development of the gastric ulcers. On the other hand, in the recent past, some
believed that natural tree resin extract, mastic gum, actively eliminates the H. pylori
bacteria. However, multiple subsequent studies have found no effect of using mastic
gum on reducing H. pylori levels.
Epidemiology
The lifetime risk for developing a peptic ulcer is approximately 10%. In
Western countries the prevalence of Helicobacter pylori infections roughly matches
age (i.e., 20% at age 20, 30% at age 30, 80% at age 80 etc). Prevalence is higher in
third world countries. Transmission is by food, contaminated groundwater, and
through human saliva (such as from kissing or sharing food utensils). A minority of
cases of Helicobacter infection will eventually lead to an ulcer and a larger
proportion of people will get non-specific discomfort, abdominal pain or gastritis.
Peptic ulcer disease had a tremendous effect on morbidity and mortality until
the last decades of the 20th century, when epidemiological trends started to point to
an impressive fall in its incidence. The reason why the rates of peptic ulcer disease
decreased is thought to be the development of new effective medication and acid
suppressants and the discovery of the cause of the condition, H. pylori.
In the United States about 4 million people have active peptic ulcers and
about 350,000 new cases are diagnosed each year. Four times as many duodenal
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ulcers as gastric ulcers are diagnosed. Approximately 3,000 deaths per year in the
United States are due to duodenal ulcer and 3,000 to gastric ulcer.
Synthesis of gastric HCl
H+ and K ATPase. The enzyme is stimulated by protein kinases, activated by
histamine and by acetylcholine and gastrin.
The two ions H+ and Cl- unite within the canaliculus of parietal cell to form HCl and
HCl form in to the gastric lumen.
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1.3 THE REGULATION OF ACID SECRETION
The regulation of acid secretion by parietal cells is especially important in
the pathogenesis of peptic ulcer, and constitutes a particular target for drug action.
The secretion of the parietal cells is an isotonic solution of HCl (150 mmol/l) with a
PH less than 1, the concentration of hydrogen ions being more than a million times
higher than that of the plasma. The Cl- is actively transported into canaliculi in the
cells that communicate with the lumen of the gastric glands and thus with the
stomach itself. This Cl- secretion is accompanied by K+, which is then exchanged for
H+ from within the cell by a K+/H+ ATPase and bicarbonate ions. The latter
exchanges across the basal membrane of the parietal cell for Cl-.
The principal stimuli acting on the parietal cells are:
 Gastrin (a stimulatory hormone)
 Acetylcholine (a stimulatory neurotransmitter)
 Histamine (a stimulatory local hormone)
 Prostaglandins E2 and I2 (local hormones that inhibit acid secretion).
Gastrin is a peptide hormone synthesized in the mucosa of the gastric antrum
and duodenum, and secreted into portal blood. Its main action is stimulation of the
secretion of acid by the parietal cells. These receptors are blocked by proglumide
which inhibits gastrin action. Gastrin also indirectly increases pepsinogen secretion,
stimulates blood flow and increases gastric motility. Release of this hormone is
controlled both by neuronal transmitters and blood- borne mediators.
Acetylcholine is released from neurons and stimulates specific muscarinic
receptors on the surface of the parietal cells and on the surface of histamine-
containing cells
Histamine: Within the stomach, mast cells (or histamine-containing cells
similar to mast cells) lying close to the parietal cell release a steady basal release of
histamine, which is further increased by gastrin and acetylcholine. The hormone acts
on parietal cell H2 receptors, which are responsive to histamine concentrations that
are below the threshold required for vascular H2 receptor activation.
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The parietal cell itself has H2 receptors for histamine and muscarinic M2
receptors for acetylcholine, as well as receptors for gastrin itself. Acid secretion
follows after the synergistic stimulation of H2 receptors (which increases cAMP),
and M2 and gastrin receptors (which increase cytosolic Ca2+).
Prostaglandins (mainly E2 and I2), synthesized in the gastric mucosa mainly
by cyclo-oxygenase-1, stimulate mucus and bicarbonate secretion, decrease acid
secretion and cause vasodilatation, all of which serve to protect the stomach against
damage. This probably explains the ability of many non-specific non-steroidal anti-
inflammatory drugs to cause gastric bleeding and erosions. More selective cyclo-
oxygenase-2 inhibitors such as celecoxib and rofecoxib appear to cause less
stomach damage. Other notable factors influencing HCl secretion include
1. Calcium
2. Alcohol
3. Coffee
4. Acidity of gastric content
5. Food fat.
1.4 Peptic Ulcer Disease pathophysiology
The pathophysiology of peptic ulcer disease is best viewed as an imbalance
between mucosal defense factors (bicarbonate, mucin, prostaglandin, nitric oxide,
and other peptides and growth factors) and injurious factors (acid and pepsin). On
average, patients with duodenal ulcers produce more acid than do control subjects,
particularly at night (basal secretion). Although patients with gastric ulcers have
normal or even diminished acid production, ulcers rarely if ever occur in the
complete absence of acid. Presumably, a weakened mucosal defense and reduced
bicarbonate production contribute to the injury from the relatively lower levels of
acid in these patients. H. pylori and exogenous agents such as nonsteroidal anti-
inflammatory drugs (NSAIDs) interact in complex ways to cause an ulcer. Up to
60% of peptic ulcers are associated with H. pylori infection of the stomach. This
infection may lead to impaired production
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Treatment of Helicobacter pylori Infection
H. pylori, a gram-negative rod, has been associated with gastritis and the
subsequent development of gastric and duodenal ulcers, gastric adenocarcinoma, and
gastric B-cell lymphoma. Because of the critical role of H. pylori in the pathogenesis
of peptic ulcers, to eradicate this infection is standard care in patients with gastric or
duodenal ulcers. Provided that patients are not taking NSAIDs, this strategy almost
completely eliminates the risk of ulcer recurrence. Eradication of H. pylori also is
indicated in the treatment of mucosa-associated lymphoid tissue lymphomas of the
stomach, which can regress significantly after such treatment.
Many regimens for H. pylori eradication have been proposed. Evidence-
based literature review suggests that the ideal regimen in this setting should achieve
a cure rate of at least 80%. Five important considerations influence the selection of
an eradication regimen. First, single-antibiotic regimens are ineffective in
eradicating H. pylori infection and lead to microbial resistance. Combination therapy
with two or three antibiotics (plus acid-suppressive therapy) is associated with the
highest rate of H. pylori eradication. Second, a proton pump inhibitor or H2-receptor
antagonist significantly enhances the effectiveness of H. pylori antibiotic regimens
containing amoxicillin or clarithromycin.
Third, a regimen of 10 to 14 days of treatment appears to be better than
shorter treatment regimens; in the United States, a 14-day course of therapy
generally is preferred. Fourth, poor patient compliance is linked to the medication-
related side effects experienced by as many as half of patients taking triple-agent
regimens, and to the inconvenience of three- or four-drug regimens administered
several times per day. Packaging that combines the daily doses into one convenient
unit is available and may improve patient compliance.
Finally, the emergence of resistance to clarithromycin and metronidazole
increasingly is recognized as an important factor in the failure to eradicate H. pylori.
Clarithromycin resistance is related to mutations that prevent binding of the
antibiotic to the ribosomes of the pathogen and is an all-or-none phenomenon. In
contrast, metronidazole resistance is relative rather than absolute and may involve
several adaptations by the bacteria. In the presence of in vitro evidence of resistance
to metronidazole, amoxicillin should be used instead. In areas with a high frequency
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of resistance to clarithromycin and metronidazole, a 14-day, quadruple-drug regimen
(three antibiotics combined With a proton pump inhibitor) generally is effective
therapy.
NSAID-Related Ulcers
Chronic NSAID users have a 2% to 4% risk of developing a symptomatic
ulcer, gastrointestinal bleeding, or perforation. Ideally, NSAIDs should be
discontinued in patients with an ulcer if at all possible. If continued therapy is
needed, selective COX-2 inhibitors may be considered, although this does not
eliminate the risk of subsequent ulcer formation and the possible association of these
drugs with adverse cardiovascular events mandates caution. Healing of ulcers
despite continued NSAID use is possible with the use of acid-suppressant agents,
usually at higher doses and for a considerably longer duration than standard
regimens (e.g., 8 weeks or longer). Again, proton pump inhibitors are superior to H2-
receptor antagonists and misoprostol in promoting the healing of active ulcers
(healing rates of 80% to 90% for proton pump inhibitors versus 60% to 75% for the
H2-receptor antagonists), and in preventing recurrence of gastric and duodenal ulcers
in the setting of continued NSAID administration.
Stress-related ulcers
Stress ulcers are ulcers of the stomach or duodenum that occur in the context
of a profound illness or trauma requiring intensive care. The etiology of stress-
related ulcers differs somewhat from that of other peptic ulcers, involving acid and
mucosal ischemia. Because of limitations on the oral administration of drugs in
many patients with stress-related ulcers, intravenous H2-receptor antagonists have
been used extensively to reduce the incidence of GI hemorrhage due to stress ulcers.
Now that intravenous preparations of proton pump inhibitors are available, it is
likely that they will prove to be equally beneficial. However, there is some concern
over the risk of pneumonia secondary to gastric colonization by bacteria in an
alkaline milieu...
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Fig. 02: Gastric ulcers
Zollinger-Ellison Syndrome
Patients with this syndrome develop pancreatic or duodenal gastrinomas that
stimulate the secretion of very large amounts of acid, sometimes in the setting of
multiple endocrine neoplasia, type I. This can lead to severe gastroduodenal
ulceration and other consequences of uncontrolled hyperchlorhydria. Proton pump
inhibitors clearly are the drugs of choice, usually given at twice the routine dosage
for peptic ulcers with the therapeutic goal of reducing acid secretion to 1 to 10
mmol/h.
Nonulcer Dyspepsia
This term refers to ulcer-like symptoms in patients who lack overt
gastroduodenal ulceration. It may be associated with gastritis (with or without H.
pylori) or with NSAID use, but the pathogenesis of this syndrome remains
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controversial. Although empirical treatment with acid- evidence of their benefit in
controlled trials suppressive agents is used routinely in patients with nonulcer
dyspepsia, there is no convincing.
Fig.03: Peptic ulcer of duodenum
1.5 Peptic ulcer
First part of your small intestine. If peptic ulcers are found in the stomach,
they’re called gastric ulcers. If they’re found in the duodenum, they’re called
duodenal ulcers.  You can have more than a peptic ulcer is a sore in the lining of
your stomach or duodenum.  The duodenum is the One ulcer. Many people have
peptic ulcers.  Peptic ulcers can be treated successfully.  Seeing your doctor is the
first step. Peptic ulcers occur in the wall of the stomach and duodenum.
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Acute ulcer
 Usually associated with sepsis, injection (cytomegalo-virus) [CMV],
Candida, tuberculosis [TB], syphilis), surgery/trauma, central nervous
system (CNS) injury or disease (Cushing’s disease), extensive burns
(Curling’s ulcer), use of drugs (aspirin, steroid), or after radiation therapy
 If superficial, involving mucosa only (erosion), can heal completely
 If deep, fibrosis replaces muscle and perforation may occur
Microscopic
 Marked epithelial atypia
Chronic ulcer
 Cardinal symptom is nocturnal epigastric pain
 Associated with achlorhydria
 95% along the lesser curvature
 95% accuracy with endoscopic and 70% accuracy with radiographic
diagnosis
 Questionable risk of malignancy Macroscopic
 5% multiple
 Sharp delineation.
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Causes of peptic ulcers
Peptic ulcers occur in 5-20% of longterm NSAID use.
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) are a group of
medications typically used to treat pain.  There are many drugs in this group.  A few
of these include: aspirin, oxaprozin . NSAIDs are also included in some combination
medications, such as Alka-Seltzer, Acetaminophen and is therefore the preferred
non-prescription treatment for pain in patients at risk for peptic ulcer disease.
Because NSAIDs are so common, and because many are available over the
counter without a prescription, they are a very common cause of peptic ulcers.
NSAIDs cause ulcers by interrupting the ability of the stomach and the duodenum to
protect themselves from naturally occurring stomach acid.  NSAIDs also can
interfere with blood clotting.  This has obvious Importance when ulcers bleed.
People, who take NSAIDs for a long time, at high doses or both, have a higher risk
of developing ulcers.  These people should discuss preventing ulcers with their
physician.  A PPI can prevent or significantly reduce the risk of an ulcer being
caused by NSAIDs.
Helicobacter pylori
A bacterium called Helicobacter pylori (H. pylori) is a major cause of peptic
ulcers.
1. Duodenal Ulcer: 90-100% Prevalence
2.   Gastric Ulcer: 70-90% Prevalence .
H. pylorus causes more than half of peptic ulcers worldwide.
The bacterium causes peptic ulcers by damaging the mucous coating that
protects the stomach and duodenum Damage to the mucous coating allows powerful
stomach acid to get through to the sensitive lining beneath.  Together, the stomach
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acid and H. pylori irritate the lining of the stomach or duodenum and cause an ulcer.
Yet, most people infected with H. pylori never develop ulcers. Why the bacterium
causes ulcers in some people and not in others is not known.  Most likely,
development of ulcers depends on characteristics of the infected person; the type, or
strain,of H. pylori present; and factors researchers have yet to discover.
Acid Induced Ulcers
1. Idiopathic
2. Zollinger-Ellison Syndrome.
Other medication
Steroids, bisphosphonates, potassium chloride, chemotherapeutic agents
(e.g., intravenous fluorouracil)
Rare
Acid-hypersecretory
states(e.g.,Zollinger-
Ellison syndrome)
Multiple gastroduodenal, jejunal, or esophageal ulcers
Malignancy Gastric cancer, lymphomas, lung cancers
Stress
Genetic factors
After acute illness, multiorgan failure, ventilator support,
extensive burns (Curling's ulcer), or head injury
(Cushing's ulcer).
People with blood group ‘O’ appear to be more prone to
develop peptic ulcers than those with other blood groups.
Genetic influences appear to have greater role in
duodenal ulcers as evidenced by their occurrence in
families, monozygotic twins and association with HLA-
B5 antigen.
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1.6 MEASURE TO CONTROL GASTRIC ACIDITY
 Neutralizing gastric acid using antacids.
 Inhibiting the gastric acid secretion with drugs
 Cessation of smoking
 Withdrawal of gastric acid secretion stimulants such as alcohol, caffeine
and
 Soft cola drinks
 Surgical treatment such as partial gastrectomy or vagotom.
1.7 PEPTIC ULCER THERAPY
PRINCIPLES OF PEPTIC ULCER THERAPY
As the precise cause of peptic ulcer is not known, therapy is still empirical it
consists of
 Controlling gastric acidity, hyper motility & sperm, thus relining the
associated pain
 Promoting ulcer healing
 Prevention of complications & recurrence
 Treatment of H pylori infections
Reduction of gastric acid secretion
1. Proton pump inhibitors: Pantoprazole, Omeprazole, lansoprazole,
Rabeprazole.
2. H2-Receptor antagonists: Cimetidine, Ranitidine, Famotidine, Nizatidine.
2. Anticholinergics: Pirenzepin, propantheline, Oxyphenonium.
3. Prostaglandin Analogs: Misoprostol.
Neutralization of gastric acid (Antacid)
1. Antacids: Sodium bicarbonate, Sodium citrate, Magnesium hydroxide,
Calcium carbonate.
2. Ulcer protectives: Sucralfate, Colloidal bismuth subcitrate.
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3. Ulcer healing drugs: Carbenoxolone sodium
4. Anti-H. pylori drugs: Amoxicillin, Clarithromycin, Metronidazole,
Tetracycline.
1.8 INFLAMMATION
Inflammation is the protective response of the living individual to get rid of
the cause and effect of injury (microbes, toxins, necrotic tissues).
A free-living cell, whether prokaryotic or eukaryotic, must establish
structural and functional barrier between its internal and hostile environment.
Unicellular organisms (amoeba) selectively admit some and exclude or
extrude others.
Multicellular organisms protect themselves by different cells to perform
different functions.
Example:
- Storage of nutrients (liver cells)
- Communication (neurons)
- Contractile activity of muscles (heart)
- Synthesis of proteins and peptides from exports (liver, pancreas, endocrine cells)
- Absorption (intestine)
- Defense against foreign invaders (neutrophils, lymphocytes, macrophages) .
Inflammation is described in the Egyptian papyrus (3000BC).
In the first century, the Roman writer Celsus described 4 cardinal signs of
inflammation (rubor, tumor, calor, and dolor). The fifth cardinal sign, the functio
laesa was added by Virchow.In 1793, John Hunter noted that inflammation is not a
disease but is a beneficial response of the host The detail vascular changes in
inflammation was recorded by Julius Cohnheim (1839- 1884).In 1882, Elie
Metchnikoff described that phagocytes engulf the offending agents to destroy and
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remove them (hence phagocytes accumulate in inflammation). Paul Ehrlich
described that factors in the serum is needed to neutralize the infective agents. It
soon became clear that both cellular (phagocytes) and serum factors (antibodies) are
important defense against microorganisms. Thomas Lewis established that chemical
substances such as histamine locally induced by injury mediate the vascular changes
in inflammation. Thus, at the present century, knowledge of inflammation has
reached from cellular age to the chemical and molecular age
Definition: Inflammation of prolonged duration (weeks and months), in
which active inflammation, tissue destruction and healing occur simultaneously.
Acute inflammation is characterized by vascular changes, edema and
neutrophilic infiltration, where as chronic inflammation is characterized by
infiltration of mononuclear cells i.e. macrophages, lymphocytes and plasma cells
along with tissue destruction and repair by fibrosis.
Causes
1. Following acute inflammation due to persistence of the injurious agent or
interference of healing. Example: Acute osteomyelitis
1. Repeated bouts of acute inflammation. Example: duodenal ulcer. Peptic
Ulcer
2. Low intensity injurious agents:
(i) Intracellular low toxicity microbes. Example: Mycobacterium
Tuberculosis, T. pallidum, virus, fungi etc. Infectious Disease Online-
India.
(ii) Toxic agents. Example: Silica , asbestosis. Visit: Silicosis ;
(iii) Immune reactions. Example: autoimmune diseases
Granulomatous Inflammation
It is a distinctive pattern of chronic inflammation, in which the predominant
cells are activated macrophages, which are enlarged, oval or elongated with
indistinct cell boundary and called epithelioid cells. Diagnosis of granuloma rests on
the identification of epithelioid cells. Epithelioid cells may coalesce to form
multinucleated giant cells (Visit: Tuberculosis ).
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Two types of granuloma
(i) Foreign body: Incited by inert foreign bodies. Example: suture materials,
splinter, breast prosthesis, silica, asbestos etc. foreign body granuloma ; Silicone
granulomas
(ii) Immune granulomas: It is Type IV hypersensitivity and mediated by T-cells,
typically seen in tuberculosis.
Microscopically, granuloma is characterized by aggregation of epithelioid
cells surrounded by lymphocytes. Epithelioid cells often fuse to form multinucleated
giant cells. Giant cells with nuclei dispersed to the periphery of the cells are called
Langhans type of giant cells.
Examples of Granulomatous inflammations:
Bacteria: Tuberculosis (Mycobacterium Tuberculosis) ; Leprosy
(Mycobacterium Leprae); Syphilitic Gumma (T. pallidum); Cat Scratch Disease
(gram-negative bacillus).
Parasite: Schistosomiasis.
Fungus: Histoplasma Capsulatum ; Blastomycosis ; Cryptococcus
neoformis; Coccidioides immitis.
Inorganic metals and dusts: Silicosis ; Berylliosis. (Pneumoconiosis ;
Silicosis ; Asbestosis ; Coal Pneumoconiosis ; Talcosis)
Foreign body: Suture materials ; Breast prosthesis ; Splinters. Foreign
body granuloma ; Silicone granuloma
Acute inflammation is the immediate and early response to injury,
characterized mainly by vascular changes with delivery of leucocytes to the site of
injury to clear the invaded bacteria and damaged tissue.
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(i) Cardinalsigns
1. Rubor (redness) due to dilatation of arterioles
2. Calor (heat)
3. Dolor (pain) due to pressure on nerve endings by edema fluid and
chemical mediator bradykinine
4. Tumor (swelling) due to edema.
5. Functio laesa (loss of function) due to inhibition of movement by pain
and tissue necrosis.
Sequence of vascular changes
1. Transient vasoconstriction of arterioles may be due to:
i) direct mechanical stimulation of capillaries
ii) Local axon reflex (vasoconstrictor fibers).
2. Persistent vasodilation - first arterioles, followed by opening of capillary
beds, caused by chemical mediators.
3. Increased blood flow mainly due to arteriolar dilatation and opening of capillary
beds.
4. Slowing of the circulation (Stasis) due to
i) Increased viscosity of blood due to fluid loss
ii) Swollen capillary endothelium due to toxin.
5. Flow of protein-rich fluid into extra-vascular space called inflammatory exudates.
Inflammatory Exudates: due to:
(i) increased intra-vascular hydrostatic pressure.
(ii) Increased permeability due to endothelial contraction with
increased inter cellular gaps, of the venules.
(iii) Direct endothelial injury and detachment, involving venules,
capillaries and arterioles.
(iv) Increased tissue osmotic pressure.
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6. Margination and immigration of leucocytes
Normally red and white cells flow intermingled in the center of the vessel
forming axial stream, separated from vessel wall by a clear cell-free plasmatic zone.
Due to slowing of the circulation, leucocytes fall out of the axial stream and come to
plasmatic zone known as margination of leucocytes. Leucocytes gradually adhere to
the vessel wall known as pavementing of the leucocytes. Leucocytes squeeze
between the endothelial cells by the process of diapedesis and migrate through the
vessel wall into the interstitial tissue, a process known as emigration of leucocytes
(first neutrophils followed by monocytes and lymphocytes). Emigrated leucocytes
move towards the site of injury under the influence of chemo tactic agents & the
process is called chemotaxis.
Termination of Acute Inflammation
1. Complete resolution- when minimal or no tissue damage and the involved
tissues regenerate, there is restitution to normal structure. Example: Lobar
pneumonia, acute infective hepatitis.
2. Healing by fibrosis - when there is substantial tissue destruction and the
involved tissues do not regenerate. Example: Acute rheumatic carditis
3. Dissemination - cellulites, septicemia.
4. Progression to chronic inflammation-Example: Acute osteomyelitis
Types of acute inflammation
1. Catarrhal type- Mild inflammation in mucous membrane and is characterized by
copious outpouring of mucus along with desquamated epithelial cells and a few
leucocytes. Example: Common cold, catarrhal appendicitis etc.
2. Serous type- Mild inflammation in serous surface such as pleural cavity joint
cavity etc with accumulation of low protein containing fluid (effusion). Example:
Tuberculosis pleurisy. It is also seen due to repeated mild trauma. Example:
Common blisters.
3. Fibrinous type- Characterized by outpouring of exudates with high protein and
less volume. Commonly seen in serous surface such as pleura, peritoneum, and
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pericardium. Two contiguous surfaces covered in fibrin tend to stick together and if
not lysed scar tissue is formed with permanent loss of function - Example: Adhesive
and constrictive pericarditis. Lobar Pneumonia due to Streptococcus pneumoniae is
associated with massive fibrinous exudates in the lung alveoli. Visit: Pericardial
Disease
Lobar pneumonia shows massive fibrinous inflammatory exudates in alveoli.
4. Membranous type- Fibrinous inflammation in which network of fibrin
entangling inflammatory cells and bacteria forms pseudo-membrane. Example:
Diphtheria , Bacillary dysentery. Pseudomembranous inflammation in diphtheria
showing network of fibrin entangling inflammatory cells. Bacteria forming pseudo-
membrane (left).
5. Suppurative or purulent type- Usually caused by pyogenic bacteria and is
characterized by pus formation Example: Abscess.
Abscess
Abscess is the localized collection of pus, commonly seen solid block of
tissue - Example: dermis, liver, kidney, brain etc. Pus consists of partly or
completely liquified dead tissue mixed with dead or dying neutrophils and living or
dead bacteria, Pyemic abscess in myocardium. Abscess containing necrotic cell
debris, colonies of bacteria, and large number of neutrophils, many of them
degenerate.Myocardium is on the right.
Microscopic feature
Central purulent zone is surrounded from inside outwards by, pus cells,
living neutrophils and granulation tissue known as pyogenic membrane. This last
layer represents the repair process and serves as a barrier to the spread of
inflammation. It also prevents the discharge of pus from the abscess without which
healing cannot occur. When pus is drained the granulation tissue proliferates to
replace the necrotic tissues and repair is done.
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6. Phlegmonous type- (Phlegmon means fire): Characterized by woody hardness of
the inflamed area due to low resistance of the body and high virulence of the
bacteria - Example: Erysipelas, pelvic cellulites etc.
Function of chemotactic agents
1. Recognition and engulfment of microorganisms by covering it with serum
protein (opsonin).
2. Activation of leucocytes causing liberation of oxygen metabolites, enzymes
etc. which kills the engulfed microorganisms.
3. These liberated toxic metabolites and proteases also cause tissue damage.
Different mediators are discussed separately but they are intimately related and their
actions start in sequence.
Once started, they are quickly inactivated or destroyed by enzymes or other
substances, so that inflammation may not persist.
Chemical mediators may be
1. Exogenous - microbial products
2. Endogenous.
Endogenous chemical mediators
Early phase
Vasoactive amines
1. Histamine - Source: mast cells, basophils, platelets. Action: increases vascular
permeability.
2. Serotonin (5HT) - Source: platelets. Action: similar to histamine.
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Intermediate Phase
1. Kinin system
Kallikrein (Plasma substrate): i) Plasma - Bradykinin ; ii) Tissue - Kallidin. Action:
i) Pain and increased vascular permeability ; ii) Chemotaxis of neutrophils and
monocytes.
2.Compliment derivatives : Action: acts by increasing vascular permeability and
chemotaxis of neutrophils monocytes (3a and 5a called anaphylatoxin).
3. Permeability globulin : Present in plasma. Action: similar to compliment.
4. Leukotrienes: present in all leukocytes. Action: similar to compliment.
Late phase
1. Prostaglandins : Liberated from all leukocytes and platelets. Action: (i)
Vasodilation, pain and fever (ii) Potentiates actions of other chemical mediators.
2. Slow Reacting Substance of Anaphylaxis (SRS- A): Liberated from mast cells,
basophils and neutrophils. Action: potentiates the actions of other chemical
mediators.
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2. PLANT PROFILE
DESCRIPTION OF THE PLANT
Figure:4 - Solanum pubescens willd leaves
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 Botanical information : Solanum pubescens willd
 Family : Solanaceae
 Synonyms : Cyphomandra luteoalba (Pers.) A.Child
Cyphomandra luteoalbum (Pers.)
Solanum luteoalbum var. tunya J.F.Macbr.
Solanum pubescens Ruiz & Pav.
Vernacular Names
English :           Wild brinjal
Telugu : Mulla vankaya
Taxonomical classification
Kingdom : Plantae – Plants
Super division : Spermatophyta – seed plants
Division : Magnoliophyta – Flowering plants
Class : Magnoliopsida - Dicotyledons
Subclass : Rosidae
Order : Solanales
Family : Solanaceae
Genus :          Solanum
Species : Solanum pubescens willd
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Description:
Solanum pubescens willd. Commonly known as wild brinjal is a sherb, with
ovate 12 cm long leaves, Flowers are violet, arranged in leaf axils. Fruits are berry,
on mature orange colour, seeds are copious-drying brown, Solanum pubescens
willd.. Growing to about 2.5 metre.Its inflorescence is raceme and size up to 2.5-3
cm long. Solanum pubescens willd.. Native range extends from Africa to Asia
including India, Philippines, China, Indonesia, Malaysia, and Thailand
Habitat:
Solanum pubescens willd.. is widely distributed throughout the tropics
and can be found both in wild ,among thron plants&road edges, states on the
plains of India. (Muthu karthick et al 2010)
.
Propagation : By seeds
Parts used : Leaves and flowers
Chemical constituents:
The leaves of solanum pubescens willd. Contain steroids, tannins and
flavonoids. Other constituents such alkaloids, carbohydrates, resins have also been
reported. (HEMAMALINI. K et al 2011)
Uses:
The juice of the roots and leaves of the plant are considered to be useful
in treatment of asthma. The juice of the stem is used as hepato protective. The leaves
are used as poultice in the treatment of skin eruptions. The plant is used as a laxative
and analgesic. Its roots contain resins, alkaloids, starch, glucose, gums, fatty acids,
carbonic acid. Besides these, it contains minerals like Ca, Fe, and Ph.
(HEMAMALINI. K et al 2011)
.
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3. LITERATURE RIVIEW
 P. Thirunavukkarasu et al., 2009 has studied the Anti-ulcer Activity of
Excoecaria agallocha bark on NSAID-induced Gastric Ulcer in Albino Rats.
The plant extract of Excoecaria agallocha bark herbal preparation has been
used in the treatment of varies diseases such as in anti tumor, anti microbial,
anti wound killing agents and anti oxidant. The study report showed that the
gastro protective effect of E. agallocha in a model of NSAID induced ulcer rat.
The lyophilized extract was given by oral gavages (125 and 62.5mg/kg) three
times at 12 h intervals before administering dicolofenac 100mg/kg.
Pretreatment with the extract resulted in a significant decreased of the
ulcerated area. The volume and acidity of the gastric juice decreased in the
pretreated rats. The plant extract was elevated in the gastric juice of untreated
rats, showed hear normal levels in the pretreated rats. The E. agallocha was
able to decrease the acidity and increase the mucosal defense in the gastric
areas, there by justifying its use as an antiulcerogenic agent.
 HEMAMALINI. K et al., 2011 has reported that the methanolic extract of
solanam pubescens and gymnosporia emerginata leaves for its anthelmintic
activity using earthworm’s phertima posthuma. Various concentrations (10 –
35 mg /ml) of plant extract were tested in bioassay. Piperazine citrate
(10mg/ml) was used as reference standard drug whereas distilled water as
control. Determination of paralysis time and death time of the worms were
recorded. Extract exhibited significant anthelmintic activity at highest
concentration of 50 mg/ml.The result showed that methanolic extract possess
vermicidal activity and found to be effective as an anthelmintic.
 Mayank Kulshreshtha et al., 2011 has studied the effect of aqueous extract
of Ficus bengalensis (FBE) in different acute and chronic gastric ulcer models
in rats. Gastric ulcers induced in Swiss albino rats (200g, N=6) by oral
administration of aspirin suspension and pylorus ligation. The anti ulcer
activity was studied by determining and comparing the ulcer index in the test
drug groups with that of the vehicle control and standard ranitidine &
sucralfate. FBE, 250–500 mg/kg administered orally, twice daily for 5 days
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showed dose-dependent ulcer protective effect in pylorus ligation (51.28,
63.24% protection, P < 0.01 to P < 0.001), aspirin (28.94, 64.91 protection, P <
0.001). The parameters taken to assess antiulcer activity were pH of gastric
juice.
Total acidity and ulcer index. The results indicated that aqueous extract
significantly (p<0.05) Ph, total acidity and ulcer index. On the basis of
histopathology analysis, the results indicate that FBE possesses antiulcer
activity in a dose dependent manner.
 Hemant Kumar et al., 2011 has reported that Ficus religiosa is being used in
Ayurvedic and Malay traditional medicine for the treatment of various diseases
including gastric ulcer. They validated the anti-ulcer potential of the ethanol
extract of leaves of Ficus religiosa against in vivo aspirin induced ulcer and
pylorus ligation assays. Gastric ulcers induced in Swiss albino rats by oral
administration of aspirin suspension and ligate the pylorus part of stomach.
The antiulcer activity was examined by determining and comparing the ulcer
index in the test drug groups with that of the vehicle control and standards.
Therefore all models showed significant anti-ulcer property in a dose
dependent manner. The parameters taken to assess antiulcer activity were
volume of gastric juice, free deity, total acidity and ulcer index. The results
indicated that ethanolic extract significantly p<0.001) decreased the volume of
gastric acid secretions, free acidity and total acidity and ulcer index.
 M.A. Al-Yahya et al., 1988 has studied the Gastroprotective Activity of
Ginger Zingiber Officinale Rose, in Albino Rats. They studied the
cytoprotective and gastric anti-ulcer properties of ginger was carried out in
albino rats. Cytodestruction was produced by 80% ethanol, 0 .6M HCl, 0. 2M
NaOH and 2 5% NaCl. Whereas gastric ulcers were produced by ulcerogenic
agents including indomethacin, aspirin and reserpine, beside hypothermic
restraint stress and by pylorus ligated Shay rat technique. The results of this
reported that the extract in the dose of 5 0 mg/kg orally exert highly significant
cytoprotection against 8 0% ethanol, 0. 6M HC1, 0. 2M NaOH and 25% NaCl
induced gastric lesions. The extract also prevented the occurrence of gastric
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ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs) and
hypothermic restraint stress. These observations suggest cytoprotective and
anti-ulcerogenic effect of the ginger.
 MOHAMED S. KARAWYA et al., 2010 has reported that the anti-
inflammatory activity of different extracts of five plants abundantly growing in
Egypt, namely Ipomoea palmata Forsk. (Convolvulaceae), Alstonia scholaris
R.Br. (Apocynaceae), Salix subserrata Willd. Salix tetrasperma Roxb. and
Populus nigra Linn. (Salicaceae) has been studied. They studied on
Photochemical properties of selected bioactive extracts was carried out as well
as their possible mechanism of action. They reported that the anti-
inflammatory activity of the extracts under investigation to different degrees.
A chromatographic study of the bioactive lipoidal extracts of A. scholaris and
I. palmata was carried out and the results revealed the presence of unsaturated
fatty acids (linoleic and linolenic). Beta-sitosterol and campesterol were
present in A. scholaris and I. palmata, respectively. Chromatographic and
spectral investigation of the flavonoids in the bioactive aqueous extract of I.
palmata revealed the presence of luteolin, quercetin 7-glycoside and apigenin.
The anti-inflammatory activity may be due to the presence of these
phytochemical constituents.
 Ramachandran.S et al., 2011 has studied t the Evaluation of anti-
inflammatory and analgesic potential of methanol extract of Tectona grandis
flowers. They evaluated anti-inflammatory and analgesic activity of methanol
extract of Tectona grandis (T. grandis) flowers (METGF) in animal models to
support its traditional use. Acute toxicity study was performed to determine
the toxicity level of METGF in mice and rats. Carrageenan (1% w/w) was
administered and inflammation was induced in of rat paw. Analgesia was
induced by intraperitoneal injection of 0.6% v/v acetic acidin mice to assesperi
pheral analgesic of METGF also,hot-plate was used to induce pain in mice to
evaluate central analgesic action of METGF
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 Biswa Nath Das et al., 2009 has screened the Anti-inflammatory activity of
bark of Xeromphis spinosa. The bark of Xeromphis spinosa extracted by a
mixture of equal proportions of petroleum ether, ethyl acetate and methanol at
an oral dose of 200 and 400 mg/ kg body weight exhibited significant anti-
inflammatory activity when compared with control.
 Hossein Hosseinzadeh et al., 2002 has reported that the Anti-nociceptive
and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in
mice. Crocus sativus L. (saffron) is used in folk medicine, for example as an
antiedematogenic agent. They evaluated the anti-nociceptive and anti-
inflammatory activity of saffron extracts in mice. They used aqueous and
ethanolic maceration extracts of Crocus sativus L. stigma and petals. Anti-
nociceptive activity was examined using the hot plate and writhing tests. The
effect of extracts against acute inflammation was studied using xylene induced
ear edema in mice. The activity of the extracts against chronic inflammation by
formalin-induced edema in the rat paw. In the hot plate tests, intraperitoneal
injection of both extracts showed no significant anti-nociceptive activity in
mice. The extracts showed anti-nociceptive activity against acetic acid induced
writhing. Naloxone partially blocked only the antinociceptive activity of the
stigma aqueous extract. Only the stigma extracts showed weak to moderate
effect against acute inflammation. In chronic inflammation, both aqueous and
ethanolic stigma extracts, as well as ethanolic petal extract, exerted anti-
inflammatory effects. Conclusions: They conclude that aqueous and ethanolic
extracts of saffron stigma and petal have an antinociceptive effect, as well as
acute and/or chronic anti-inflammatory activity.
 Sharma U.S et al., has screened the Anti-inflammatory activity of Cordia
dichotoma forst f. seeds extracts. The effects of Cordia dichotoma forst f. seeds
extract on different phases of acute inflammation were examined.
Investigations were performed using different phlogistic agents-induced paw
edema viz., Carrageenan-induced paw oedema and Dextran- induced paw
oedema in rats. Various extracts (ethanol and aqueous) of Cordia dichotoma
forst seeds at a dose of 250 mg/kg and 500 mg/kg orally were tested.
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Diclofenac sodium at the dose of 10mg/kg was used as standard. Both the
extracts showed significant activity (*p<0.05 & **p<0.01) compared with the
control in both of these models. The dry powdered seeds were found to contain
alkaloids, glycosides, saponins, tannins and carbohydrates. Thus it is revealed
from the screening model used that the ethanol extract and aqueous fraction of
this plant possesses acute anti-inflammatory activity.
 Yazmín K. Márquez et al., 2009 has studied the Anti-inflammatory activity
of aqueous and methanolic extracts of Oenothera rosea L´ Hér. ex Ait in the
rat. Oenothera rosea L´ Hér. ex Ait. (Onagraceae) is commonly known as
hierba del golpe. It is used in Mexican Folk Medicine to treat inflammatory,
renal and bacterial diseases. They evaluated the anti-inflammatory activity of
aqueous and methanolic extracts of this plant. Aqueous extract at a dose of 500
mg/kg body weight (b.wt.) and methanolic extract (100 mg/kg b.wt.) of
Oenothera rosea were evaluated for anti-inflammatory activity using the
cotton pellet-induced granuloma formation model in rat and histological
techniques. Both extracts produced a significant decrease of the inflammatory
rocess in relation with the control groups (p<0.05). The anti-inflammatory
effect of methanolic extract was similar to the effect of indomethacin. This
data was supported by the histological results. No extracts produced
gastrointestinal damage. The LD50 of aqueous and methanol extracts, was
higher than 40 and 8 g/kg, respectively. They evaluated that both extracts of
Oenothera rosea induced anti-inflammatory activity and it was considered not
toxic.
 FAYYAZ AHMAD et al., 1992 has reported that the anti inflammatory
activity from Plant extracts of lactuca scariola and artemisia absinthium Seeds
and samples of stems from the two medicinal plants, Lactuca scariola and
Artemisia absinthium respectively were extracted in absolute methanol to
determine their analgesic and anti-inflammatory activity. They studied
analgesic activity on intact mice by tail flick latency in tail immersion method.
The anti-inflammatory activity was estimated volumetrically by measuring the
mean increase in hind paw volume of rat with the help of plethysmometer.
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Acetylsalicylic acid in the dose of 300 mg/kg is used as standard drug. Both
plant extracts were given in the doses of 300, 500 and 1000 mg/kg. Control
group received 0.9% NaCI (saline) solution. All the doses administered orally.
Results showed that Lactuca had potent analgesic activity and Artemisia had
significant analgesic and anti-inflammatory activity.
 M.J. Abada et al., 2006 has studied Anti-inflammatory activity of four
Bolivian Baccharis species (Compositae). Hexanic, dichloromethanic,
ethanolic and aqueous extracts from Baccharis obtusifolia HBK, Baccharis
latifolia (R. et P.) Pers., Baccharis pentlandii D.C. and Baccharis subulata
Wedd., plants used in the traditional medicine of South America have been
studied for their in vitro anti-inflammatory activity in cellular systems.
Calcium ionophore A23187-stimulated mouse peritoneal macrophages were
validated as a source of cyclooxygenase-1 (COX-1) (prostaglandin E2, PGE2)
and 5-lipoxygenase (5-LOX) (leukotriene C4, LTC4), and mouse peritoneal
macrophages stimulated with Escherichia coli lipopolysaccharide (LPS) were
used for testing cyclooxygenase-2 (COX-2) (PGE2), nitric oxide (NO) and
tumour necrosis factor-_ (TNF-_) activity.
 RICARDO GONZA´LEZU et al., 1999 has screened the anti-inflammatory
activity of phycocyanin extract in Acetic acid-induced colitis in rats. The anti-
inflammatory effect of c-phycocyanin extract was studied in acetic acid-
induced colitis in rats. Phycocyanin -150, 200 and 300 mg kgy1 p.o.. Was
administered 30 min before induction of colitis with enema of 1 ml of 4%
acetic acid per rat. Twenty-four hours later myeloperoxidase _MPO activity
was determined as well as histopathological and ultrastructural studies were
carried out in colonic tissue. Phycocyanin substantially reduced MPO activity
which was increased in the control colitis group. Also, histopathological and
ultrastructural studies showed inhibition in inflammatory cell infiltration and
reduction to some extent in colonic damage in rats treated with phycocyanin.
The probable role of antioxidative and the scavenging properties of
phycocyanin against reactive oxygen species in the anti-colitic effect is
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discussed in this paper. To our knowledge this is the first report on the anti-
inflammatory effect of phycocyanin in an experimental model of colitis
 Priyanka Vijay and Rekha Vijayvergia et al., 2010 has studied the
Analgesic, anti-inflammatory and antipyretic activity of Cissus
quadrangularis. They evaluated the analgesic anti-inflammatory and
antipyretic activity of ethanolic extract of Cissus quadrangularis in
experimental standard modals i.e. albino rats following oral administration.
The reported that the ethanolic extract significantly reduce the edema induced
by carrageenan within 1 to 5 hrs. Post dosing at all the dose levels used. On the
analgesic property acetic acid induce writhing was significantly reduce in the
formalin test, the extract also significantly decreases the painful stimulus in
both phases of test which confirms central and peripheral effects of the drugs.
Its effects on antipyretic activity were also appreciable it significantly reduces
fever at higher doses within 2 hrs. On yeast induce hyperthermia in rats.
 C. O. Okoli et al., 2005 has reported that the anti-inflammatory activity of
extracts of root bark of securidaca longipedunculata fres (polygalaceae). The
effect of extract and fractions of the root bark of Securidaca longipedunculata
Fres (Polygalaceae) on acute inflammation was evaluated. Solvent extraction
yielded the crude methanol extract (ME) while solvent–guided extraction
yielded a petroleum ether fraction (PF) and methanol fraction (MF). The
extract and fractions inhibited topical edema induced by xylene in the mouse
ear. In the systemic edema of the rat paw, the methanol extract (ME) and
methanol fraction (MF) significantly (P<0.05) suppressed the development of
paw edema induced by egg albumin in rats while the petroleum ether fraction
(PF) was devoid of such activity. Ulcerogenic assay in rats indicated that the
extract and fractions exhibited varying degrees of gastric irritation in rats in the
order of magnitude: MF > PF > ME. Phytochemical tests showed that ME and
MF tested positive for carbohydrates, reducing sugars, glycosides, flavonoids,
terpenoids, sterols and saponins while PF gave positive reaction for resins
only.
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 P. Muthusamy et al., has screened the Ethanolic extract of Azima tetracantha
leaves. The extract was studied for its ulcer protective activity on aspirin and
pylorus ligation and cold restraint stress induced ulcer models.  Various
biochemical  parameters  such  as  gastric volume,  pH  of  gastric  content,
free  acidity  and  total  acidity, were examined on the test and control group
animals. The extract at a concentration of 200  and  400  mg/kg  exhibited  a
protective  effect  on  ulcer-induced  models  in  a  dose  dependent  manner
and  was comparable  with  the  standard  drugs  ranitidine  and  Omeprazole.
 R. S. Deoda et al., has studied the Gastro-protective effect of Rubia
cordifolia Linn. On Aspirin plus Pylorus-Ligated Ulcer. They studied that the
effect of Rubia cordifolia (Rubiaceae) against experimentally induced gastric
ulcer and compare activity with its fractions by employing aspirin plus
pylorus-ligated ulcer screening model in Wistar rats. Total acidity, volume of
gastric acid secretion, total acid output, and pepsin activity show significant
reduction, when compared with the control group. The study confirmed that
chloroform fraction showed the significant activity at lower doses compared to
parent extract. The mechanism can be attributed to decrease in gastric acid
secretary activity along with strengthening of mucosal defensive mechanism
by prostaglandin synthesis and antioxidant potential.
 Raju.D et al., has screened the anti-ulcer activity of Terminalia chebula fruits
in experimental rats. He investigated the anti ulcer activity of methanolic
extract of T.chebula fruits in pylorus ligated and Ethanol-induced ulcer models
in wistar rats. In both the models the common parameter determined was Ulcer
Index. The study showed that the Methanolic extract produced significant
inhibition of the gastric lesions induced by Pylorus ligation induced ulcer &
Ethanol induced gastric ulcer .The extract (250 mg/kg & 500 mg/kg) also
showed significant (P<0.01) reduction in gastric volume, free acidity and ulcer
index as compared to control.
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 Vivek Sharma and Rajini. G. P et al., have evaluated the anti-inflammatory
and anti-ulcer activities of Ethanolic and aqueous extract of aerial parts of
Caesalpinia pulcherrima (linn). Pylorus-ligation and aspirin induced models
were employed for evaluating the anti-ulcer activity of the extracts. For
evaluating the anti-inflammatory action, cotton-pellet granuloma model was
used. Ethanolic and Aqueous extracts significantly decreased the granuloma
tissue developed. Also Ethanolic and Aqueous extracts showed significant
reduction in anti-ulcer activity by decreasing ulcer score in both models of
ulcer.
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4. SCOPE OF WORK
Inflammation or phlogosis is a pathophysiological response of living tissue
to injury that leads to the local accumulation of plasmatic fluid and blood cells.
Whereas an ulcer is an erosion in the GIT which results when the lining of the GIT
gets corroded by the acidic juices secreted in the stomach. Inflammation is a
symptom and is expressed in many disease conditions like rheumatoid arthritis, gout
and some allergic reactions to name a few.
Many synthetic anti-inflammatory and anti-ulcer drugs are available in the
market but most of them are associated with many adverse and unwanted effects like
Gastro-intestinal irritation, ulceration and fluid retention. In addition to aggravating
the ulcers, NSAIDS also produce hepato-toxicity and nephro-toxicity. Since ancient
times people have been relying on plants either as prophylactic of therapeutic agents
to restore and maintain the health. Medicinal plants have been used in the
development of new drugs which may have an invaluable role in the progress of
drug discovery. Therefore a need for the development of newer anti-Inflammatory
and anti-ulcer agents from natural source with more powerful activity and lesser side
effects which act as effective substitute for chemical therapeutics.
According to ethnobotanical information the plant Solanum pubescens willd
has been used for the treatment of various conditions including ulcer and
inflammation and for the same clear scientific evidence was not proved by any
means. So, it is considered as worthful in selecting the above plant for the research
work.
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5. PLAN OF STUDY
The present study is undertaken to standardize the leaves of the plant
solanum pubescens willd and to evaluate its anti-inflammatory and anti-ulcer
activity potential with emphasize on its mechanism of action.
The study is divided into two parts
I. PHYTOCHEMICAL EVALUATION ETHANOLIC EXTRACT OF
SOLANUM PUBESCENS WILLD
1. Collection of plant (Solanum pubescens willd) leaves and shade dried.
2. Extraction of Solanum pubescens willd leaf powder using Ethanol in
soxhlet apparatus for 72 hrs.
3. Phytochemical investigation of ethanolic extract of Solanum pubescens
willd leaf.
II. PHARMACOLOGICAL EVALUATION OF ETHANOLIC EXTRACT
OF SOLANUM  PUBESCENS  WILLD
1. Anti-ulcer activity
 Pylorus ligation induced ulcer.
 Aspirin induced ulcer.
2. Anti-inflammatory activity
 Carrageenin induced paw oedema.
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6. MATERIALS AND METHODS
6.1 PLANT COLLECTION:
The leaves of Solanum pubescens willd were collected from Tirupati,
chittoor district, Andhra Pradesh. It was identified and authenticated by Prof
k.madhava chetty,Msc,Med,M.phill ,Ph.D., department of botany, sri venkateswara
university, tirupati.
6.1.1 Preparation of extract:
The leaves of Solanum pubescens willd were shade dried and then ground till
they became coarse powder in a motar-pestle. The powdered material thus obtained
was subjected to extraction using Petroleum Ether and Ethanol. The extracts
obtained were distilled to remove excess of the solvent and then evaporated at 40oC
to get a semi-solid mass. These extracts were subjected to phytochemical tests which
have been described below.
6.1.2 Animals:
Wistar rats of either sex (150-200gms) were housed in separate cages at
controlled room temperature (24 ±2oC; relative humidity 60-70%) in a 12hr light-
dark cycle. They were fed with standard pellet diet and water ad libitum.
6.2 QUALITATIVE PHYTOCHEMICAL ANALYSIS:
6.2.1 Chemical Tests:
General method followed for screening of the constituents present in the
extract is as follows.
Detection of Carbohydrates:
Extracts were dissolved individually in 5ml of distilled water & filtered. The
filtrates were used to test the presence of carbohydrates.
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1).Molisch’s Test:
Filtrates were treated with 2 drops of alcoholic α-
naphthol solution in a test tube & 2ml concentrated
sulphuric acid was added carefully along the sides
of the test tubes. Formation of violet ring at the
junction indicates the presence of carbohydrates
2).Benedict’s Test:
Filtrates were treated with Benedict’s reagent &
heated on water bath. Formation of an orange red
precipitate indicated the presence of reducing
sugars
3).Fehling’s Test: Filtrates were hydrolysed with dilute hydrochloric
acid, neutralized with alkali & heated with
Fehlings A & B solutions. Formation of red
precipitate indicates the presence of reducing
sugars.
(B). Detection of Alkaloids:
Extracts were dissolved individually in dilute hydrochloride acid &
filtered. The filtrates were tested carefully with alkaloid reagents.
1).Mayer’s Test: Filtrates were treated with Mayer’s reagent
(potassium mercuric iodide), formation of a
yellow cream precipitate indicate the presence
of alkaloids.
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2).Wagner’s Test: Filtrates were treated with Wagner’s reagent
(iodine in potassium iodide) & observed.
Formation of brown/reddish brown precipitate
indicates the presence of alkaloids.
3).Dragendroff’s Test: Filtrates were treated with dragendroff’s reagent
(solution of potassium bismuth iodide).
Formation of red precipitate indicates the
presence of alkaloids
(C). Detection of Phytosterols:
1).Salkowski’s Test: The extracts were treated with
chloroform & filtered separately. The
filtrates were treated with few drops of
concentrated sulphuric acid, shaken &
allowed to stand. If the lower layer
turns red, sterols are present. If lower
layer turns golden yellow tri-terpenes
are present.
2).Libermann Burcchard Test: The extracts were treated with
chloroform solution & few drops of
concentrated acetic anhydride solution
followed by sulphuric acid. A blue
color shows the presence of
phytosterols.
Chapter 6 Materials and Methods
Department of Pharmacology 53 J.K.K.Nattraja college of Pharmacy
(D). Detection of Glycosides:
Extracts were hydrolysed with dilutes hydrochloric acid & the hydrolysate
was subjected to glycosides tests.
(i). Test for Cardiac
Glycosides:
1).Legal’s Test:
2).Liebermann’s  Test:
To the hydrolysate 1ml of pyridine & few
drops of sodium nitro prusside solution are
added & then it is made alkaline with
sodium hydroxide solution. Color change
shows the presence of glycosides
3ml of extract with 3ml acetic anhydride
was heated, cooled then added few drops of
concentrated.sulphuric acid. Blue color
appears in presence of bufadenolids.
(ii).Test for Anthraquinone
Glycosides:
1).Borntrager’s Test:
Hydrolysate is treated with chloroform &
the chloroform layer is separated. To this,
equal quantity of dilute ammonia solution is
added. Color changes in the ammonical
layer shows the presence of ‘O’ glycoside
(zero glycosides).
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(E). Test for Deoxy Sugars (Keller Killiani Test):
To 2ml of extract, glacial acetic acid, one drop of 5% FeCl3 &
conc.H2SO4 was added. Reddish brown color appears bluish green.
(F). Test for Saponins:
1).Froth’s Test: The extracts were diluted with
distilled water to 20ml shaken in a
graduated cylinder for 15min. the
formation of 1cm layer of foam
indicates the presence of saponins.
(G).Test for Phenolic & Tannins:
6
.
3
.
D
E
1).Ferric Chloride Test: The extract was treated with few drops
of neutral ferric chloride solution. The
formation bluish black color indicates
the presence of phenolic nucleus.
2).Gelatin Test: To the extract, 1% gelatin solution
containing sodium chloride was added.
The formation of white precipitate
indicates the presence of tannins.
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(H). Test for Flavonoids:
1).Lead Acetate Test: The extracts were treated with few
drops of lead acetate solution;
formation of yellow precipitate
indicates the presence of flavonoids.
2).Alkaline Reagent Test: The extracts were treated with few
drops of sodium hydroxide
separately. Formation of intense
yellow color, which becomes
colorless on addition of few drops of
dilute acid, indicates the presence of
flavonoids
3).Shinoda Test: The extracts were treated with few
fragments of magnesium metal
separately, followed by drop wise
addition of concentrated Hcl. The
formation of magenta color indicates
the presence of flavonoids.
(I). Detection of Proteins & Amino Acids:
1).Millon’s Test: The extracts were treated with 2ml
of Millon’s reagent. The formation
of white precipitate, which turns to
red upon heating, indicates the
presence of proteins.
2).Ninhydrin Test: To the extracts, 0.25% ninhydrin
reagent was added & boiled for few
minutes. Formation of blue color
indicates presence of amino acid.
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3).Xanthoprotein test: The extract, was added with 20% of
sodium hydroxide any orange color
produced indicates presence of
aromatic amino acid. (Khandelwal,
2004)
6.3.DETERMINATION OF ACUTE ORAL TOXICITY (LD50) OF Solanum
pubescens willd
Test substance details:
Name of the test substance: Ethanolic extract of Solanum pubescens willd leaves.
Color                                  : Greenish black
Nature of the test : gummy
Substance
Experiment protocol:
Name of the study Acute toxicity
Guideline followed
OECD 425 method-acute toxic class
method
Animals
Healthy young adult non-pregnant
Swiss albino mice.
Body weight 25-30 g
Sex Male
Administration of dose and
volume
2000 mg/kg body weight, single dose
in 0.2ml
Number of groups and animals 2groups and 6animals
Route of administration Oral by using mice oral feeding needle
Vehicle Carboxy methyl cellulose(CMC)
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Housing and feeding conditions:
Room temperature 22°C  ±  3°C
Humidity 40-60%
Light 12 h : 12h (light : dark cycle)
Feed Standard laboratory animal foodpellets with water ad libitum
Study period and observation parameters:
Initial observation First 30 minutes
Special attention First 1-4 hrs after drug administration
Long term observation Up to 14 days
Direct observation parameters
Diarrhea, sitting in the corners,
sniffing excessively, standing on
hind limbs,
Additional observation parameters
Skin and fur, eyes and mucous
membrane, respiratory, circulatory,
autonomic and central nervous
systems, somatomotor activity and
behavior pattern etc.
6.3.1. Study procedure:
Acute oral toxicity was performed as per Organization for Economic Co-
operation for Development (OECD) guideline 425 methods. The extract was
administered in a single dose by gavages using specially designed mice oral needle.
Animals are fasted 24h prior to dosing (food was withheld, but not water). (OECD
Guideline for testing of chemicals 425). Ethical clearance (for handling of animals
and the procedures used in study) was obtained from the institutional Animal Ethics
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Committee before performing the study on animals. The proposal number being
22MP01DEC10.
6.4. PHARMACOLOGICAL  EVALUATION:
6.4.1 Animal selection:
Healthy adult male Wistar albino rats weighing between 150 and 200gms
were selected for the anti-ulcer studies.
6.4.2 Housing and feeding condition:
The temperature in the experimental animal room was kept 22±30C.
Artificial lighting was provided. The animals were acclimatized to standard
laboratory conditions of temperature (22 ± 30oC) and maintained on 12:12 h light:
dark cycle. The animals were housed in sanitized polypropylene cages containing
sterile paddy husk as bedding. They were provided with regular rat chow diet and
distilled water ad libitum.
6.4.3. Preparation of animals:
The animals were randomly selected and kept in their cages for at least 5
days prior to dosing to allow for acclimatization to the laboratory conditions.
6.4.4. Extracts & Standards used:
Extract used: Dried leaves of Solanum pubescens willd Ethanolic extract.
Standard used:
 Omeprazole: 20 mg/kg b.w..
 Indomethacin: 10 mg/kg b.w
Drugs, viz, Omeprazole and Indomethacin and the test extract of Solanum
pubescens willd were suspended in 0.5% CMC and used for anti-ulcer and anti
inflammatory studies. Each drug suspension was freshly prepared just before
administration.
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6.4.5. Preparation and administration of doses:
The extract was solubilised in 0.5% Carboxy Methyl Cellulose prior to
experimental use to obtain the desired concentrations (200 and 400 mg/kg body
weight) in 1 ml. The test substances were administered in a single dose using a
gastric intubation tube after fasting for 3 to 4 hrs.
6.4.6. ANTI-ULCER ACTIVITY:
6.4.6.1 Aspirin induced Gastric ulcers:
Albino rats were divided into four groups of six animals each. The weight of
the animals chosen was between 150 and 180gms. The animals were fasted 36hrs
prior to the commencement of the experiment but were allowed free access to water.
 Group I(control): 0.5% CMC
 Group II: 20mg/kg omeprazole.
 Group III: ethanolic extract at dose 400mg/kg.
 Group IV: ethanolic extract at dose 200mg/kg.
All the animals received 200mg/kg of aspirin orally to the rats. In the
treatment group, drugs were administered orally 1hr before the administration of
aspirin. After 2hrs of treatment with aspirin, animals were sacrificed by an excess
dose of ether. The stomachs were removed, opened along the greater curvature and
examined for lesions. Lesions severity was determined by ulcer index. The ulcers
were scored according to the following scale (P. Thirunavukkarasu et al 2009):
 Normal coloration – 0
 Red coloration – 0.5
 Spot ulcer – 1
 Haemorragic streaks – 1.5
 Ulcer - 2
 Perforation - 3
Mean ulcer score for each animal will be expressed as ulcer index. The
percentage of ulcer protection was determined as follows:-
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Statistical Analysis:
Statistical analysis was carried out using Graph Pad Prism5 software version
5.04 (Graph Pad prism software Inc.) The values were expressed as mean ± SEM.
The statistical analysis was carried out by one way analysis of variance (ANOVA)
followed by Dunnet’s t-test. P values< 0.05 were considered significant.
6.4.6.2. Pylorus ligation induced Gastric ulcers:
Rats were divided into four groups of six animals each. All the animals
selected for the study were of weight between 200-250gms.
 Group I (control), received, 0.5% CMC.
 Group II (reference standard) was treated with 20mg/kg omeprazole.
 Group III treated with 400 mg/kg ethanol extract of Solanum pubescens willd.
 Group IV was treated with 200mg/kg ethanolic extract of Solanum pubescens
willd.
Animals in all the groups were fasted for 36 h after the respective assigned
treatment and were anaesthetized with anaesthetic ether.  The  abdomen  was
opened  by  a  small  midline  incision below  the  xiphoid  process  and  pylorus
portion  of  stomach  was  lifted  out  and  ligated. Precaution was taken to avoid
traction to the blood supply. The stomach was sutured with interrupted sutures.
Animals were allowed to recover and stabilize in individual cages and were deprived
of water during post-operative period. Four hours after the pyloric ligation, the
animals were sacrificed by an excess dose of ether. The stomach was carefully
removed and the gastric contents were collected. The gastric juice was centrifuged at
1000rpm and gastric volume was measured.   Free and total acidites of the
supernatant were determined by titration with 0.1 N NaOH and expressed as mEq/ L
/100 gms. The stomach was cut open along the greater curvature and pinned onto a
% = ( )− ( )× 100
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soft board for evaluating the gastric ulcers and to calculate ulcer index. Ulcer
scoring is done according to the scale mentioned below.
Ulcer Index:
After  the  incision  of  the  stomach  at  the  greater  curvature  the  ulcers
were  observed.  And  the number  of  ulcers  was  counted  using  a  magnifying
glass  and the  diameter  of  the  ulcers  were measured using vernier calipers. The
following arbitrary scoring system  was used to grade the incidence and severity of
lesions.
 Normal coloration – 0
 Red coloration – 0.5
 Spot ulcer – 1
 Hemorrhagic streaks – 1.5
 Ulcer - 2
 Perforation - 3
Determination of Free Acidity and Total Acidity:
The gastric contents were centrifuged at 1000rpm for 10mins. 1ml of
supernatant was diluted with 9ml distilled water. A volume of 2ml diluted gastric
juice was treated with 0.1 N sodium hydroxide run from a micro burette using 3-4
drops of Topfer’s reagent as indicator until a canary yellow colour was observed.
The volume of NaOH run down was noted. This corresponds to free acidity.
Further, 2-3 drops of phenolphthalein was added and titrated with NaOH
until pink colour was restored. This gives total acidity.
Free acidity and Total acidity are expressed in terms of ml of 0.1N HCl per
100 gms of gastric contents. This is the same as mEq/lit. Acidity may be calculated
by using
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The following formula:
6.4.6.3. Histopathological Evaluation:
The gastric tissue samples were fixed in neutral buffered formalin solution
for duration of 24 hrs. Sections of tissue from stomachs were examined
histopathologically to study the ulcerogenic and/ or anti-ulcerogenic activity of
ethanolic extract of Solanum pubescens. The tissues were fixed in 10% buffered
formalin and were processed using a tissue processor. These sections were stained
with hematoxylin and eosin using routine procedures. The slides were examined
microscopically for Pathomorphological changes such as congestion, haemorrhage,
oedema and erosions using an arbitrary scale for the assessment of severity of these
changes (P. Thirunavukkarasu et al., 2009).
= 1000.1 /
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6.4.3. ANTI-INFLAMMATORY ACTIVITY:
6.4.3.1. Carrageenin Induced Paw Oedema in Rats:
Male wistar rats weighing between 150-180gms were used for the study. The
animals were divided into 3groups (n=5). The first group received 0.5% Carboxy
Methyl Cellulose (1ml/kg p.o) served as control, while the second group received
reference drug Indomethacin (20mg/kg p.o). The third and fourth group of animals
were administered with 400mg/kg and 200mg/kg of ethanolic extract of Solanum
pubescens willd respectively by oral route. Acute inflammation was produced by the
sub-plantar administration of 0.1% Carrageenin (in 0.9% normal saline) in the right
hind paw of the rats. The paw thickness was measured at 0min, 30min, 60min,
120min and 240min after carrageenin injection by using vernier calipers. The
animals were pretreated with the test drugs 1hour before the administration of
Carrageenin (perez et al., 1995).
Statistical Analysis:
Statistical analysis was carried out using Graph Pad Prism5 software version
5.04 (Graph Pad prism software Inc.) The values were expressed as mean ± SEM.
The statistical analysis was carried out by one way analysis of variance (ANOVA)
followed by Dunnet’s t-test. P values< 0.05 were considered significant.
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7. RESULTS
The ethonolic extract of Solanum pubescens willd was subjected to
Phytochemical and pharmacological screening. Pharmacological screening involved
the evaluation of anti-ulcer and anti-inflammatory activities. The results of the
ethonolic extract of solanum pubescens has been documented below.
7.1 RESULTS OF PRELIMINARY PHYTOCHEMICAL EVALUATION:
The colour of the Alcoholic test extract (Ethonolic extract of Solanum
pubescens willd) was found to be dark green in colour and the consistency was
found to be sticky. The extracts were subjected to phytochemical screening for the
presence of type of phyto-constituents. The phytochemical screening revealed that
ethonolic extract contains resins, alkaloids, Phytosterols, Phenols and Flavonoids.
Of the phytosterols, the ones identified were triterpenes. The results has been
tabulated in the table no.3 showing various phytoconstituents in the extract.
Table No. 3
Phytoconstituents
Extracts
Petroleum ether Ehonol
Carbohydrates - +
Glycosides - -
Alkaloids - +
Phytosteroids - _
Flavonoids - +
Protein and amino acids - -
Saponin - _
Phenols & tannins - +
Anthaquinone Glycosides - -
Triterpenoids - +
(-) represents Absence; (+) represents Presence.
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7.2. ACUTE TOXICITY STUDY:
Ethonolic Extract of Solanum pubescens willd did not produce any toxic
symptoms or mortality up to the dose level of 2000 mg/kg body weight. There was
neither change in behavioral pattern nor any sign of toxicity during the observations
up to 24hrs for mortality. Thus the extract was considered to be safe for
pharmacological evaluation. Biological evaluation was carried out at doses of 200
and 400mg/kg.
Toxicological evaluations of ethonolic extract of Solanum pubescens willd:
Effect of ethonolic extract of Solanum pubescens willd on mice.
TABLE NO: 4 acute oral Toxicity study (425) observations.
S.NO Response
1 Alertness N
2 Grooming A
3 Anxiety A
4 Roaming N
5 Sniffing N
6 Tremors A
7 Convulsion A
8 Depression N
9 Gripping strength N
10 Scratching A
11 Defecation A
12 Writhing N
13 Pupils N
14 Urination N
15 Salivation N
16 Skin colour N
17 Lacrimation N
N-Normal,A-Abscent
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Result: From acute toxicity study it was observed that the administration of
Ethonolic extract of Solanum pubescens willd to mice did not induce any toxicity
of extract and mortality in the animals up to 2000mg/kg orally.
7.3. PHARMACOLOGICAL EVALUATION:
Evaluation of two activities, Anti-ulcer activity and anti-inflammatory
activity, was carried out for the ethonolic extract of the plant.
Anti-ulcer was performed by two models,
i. Aspirin-induced gastric ulcers.
ii. Pylorus ligation induced ulcer.
The evaluation of Anti-inflammatory activity was carried out by means of
Standard model:
i) Carrageenin induced hind paw oedema.
7.3.1. Anti-Ulcer Evaluation:
7.3.1.1Aspirin Induced gastric ulcers:
Table no: 5 shows the apparent effect of Omeprazole and Extract on the
Ulcer Index and extent of mucosal damage in the stomach. In Group I i.e. control
animals, oral administration of aspirin produced characteristic lesions in the
glandular portion of rat stomach which appeared as elongated bands of thick, black
& dark red lesions. Group II animals, pretreated with the standard drug,
Omeprazole, showed considerable protection from ulcer in gastric mucosa. And in
case of Group III and IV, EESP significantly reduced the ulcer Index at 400mg/kg
and 200mg/kg doses to and respectively. Omeprazole as reference had the ulcer
protection of. The intensity of heamorrhage and lesions was significantly reduced
upon pretreatment, revealing the protective effect of EESP.
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Table No. 5
Groups Ulcer Index % Protection
Group I- Control 12.24±0.06 --
GroupII-
Standard(omeprazole) 3.49±0.08*** 71.48 %
Group III – s.pubescens willd
Extract 400mg 4.5±0.10*** 63.23%
Group IV – s.pubescens willd
Extract 200mg 5.72±0.05* 53.26 %
All values represent Mean ± SEM, n=6 in each group. P < 0.05. Control
group (Group I) is compared with standard and extract doses, * represents
significance.
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ULCER IMAGES (Aspirin Induced Ulcers):
(A) (B)
(C) (D)
(A)– Control; (B) – Standard; (C) – Extract 400mg/kg; (D) – Extract
200mg/kg
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HISTOPATHOLGY IMAGES –ASPIRIN INDUCED ULCERS
(A) (B)
(C) (D)
(A)- Control; (B) – Standard; (C) – Extract 400mg/kg; (D) – Extract 200mg/kg.
Histopathology examination:
The images and the reports demonstrate a submucosal edema with mixed
inflammatory infiltration consisting of lymphocytes and some neutrophils. The
muscularis propria appears normal intervening and the lining of epithelial cells are
seen aggregates of macrophages and neutrophils. In Group-II, the standard group
showed no damage to the gastric mucosa. The histopathological sections of group-
III, treated with EESP 400 mg/kg, shows mucosal mild edema with scattered
chronic inflammatory infiltration and congested vascular spaces. The muscular is
Chapter 7 Results
Department of Pharmacology 70 J.K.K.Nattraja college of pharmacy
propria appears normal. The section of IV- group rats shows mucosal edema with
inflammatory infiltration . The muscularis propria appears normal.
7.3.1.2. pylorus Ligation method:
In pyloric ligation induced ulcer model, Oral administration of EESP in two
different doses (200mg/kg and 400mg/kg) showed significant reduction in ulcer
index, gastric volume, free acidity, total acidity as compared to the control
group. EESP was showing protection index of 52.3% and 36.28% at the dose of
400mg/kg and 200 mg/kg respectively in comparison to control whereas
Omeprazole as reference standard drug a protection percentage of 70% has been
observed. Since the ulcer protective percentage of EESP at 200mg/kg is 36.28% it
can be considered to be less significant in the context of the study.
Table No. 6
Groups Ulcer Index % Protection
Group I- Control 11.3 ± 0.11 --
GroupIIStandard(omeprazole) 3.39 ± 0.07*** 70%
GroupIII-S.pubescens willd
Extract 400mg 5.48 ± 0.07*** 52.3%
GroupIVS.pubescens willd
Extract 200mg 7.2 ± 0.06
* 36.28%
All values represent Mean ± SEM, n=6 in each group. P < 0.001. Control group is
compared with standard and extract doses.
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Graph No. 2
Gastric volume, Free Acidity and Total Acidity:
The results of various acid secretory parameters such as Gastric volume, pH,
Free acidity and Total acidity of ethonolic extract  of solanum pubescens willd on
pylorus  ligation induced  gastric  ulcer  in  rats  are  summarized in  Table No 7.
Estimation of acid secretory parameters was increased significantly in the control
group. Administration of EESP exhibited a significant (p < 0.001) reduction in all
the parameters and the results were comparable with the standard drug Omeprazole
20mg/kg. In control group the mean gastric juice was 3.52ml.  Omeprazole, the
standard drug decreased the mean gastric volume (1.28ml), which is statistically
significant. Apart from the standard, ethnologic extract also showed decrease in the
mean gastric juice at both the doses of 400 and 200mg/kg. The extracts reduced the
mean gastric juice volume to 1.59ml and 1.86ml respectively. The test extracts
showed the decreased in gastric juice volume on comparison to control group and
thus indicate their anti-secretary mechanism. This demonstrates the dose dependent
effect of EESP.
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Table No. 7
Group
Gastric
Volume
pH Free Acidity Total Acidity
Control 3.52 ± 0.02 1.41 ± 0.12 55.01 ± 2.28 67.79 ± 1.31
Std(omeprazole) 1.28±0.05*** 5.21±0.13*** 20.90±0.76*** 32.06±3.316***
Extract 400mg 1.598±0.03** 3.5±0.08*** 29.86 ± 0.77** 41.96±0.715***
Extract 200mg 1.86 ± 0.04** 4.63±0.14*** 39.66 ± 1.14* 55.56 ± 0.99***
All values represent Mean ± SEM, n=6 in each group. P < 0.001. Control group is
compared with standard and extract doses.
Graph Comparing the amount of Gastric volume collected from each of the
Control, Standard and the Extract (400 and 200mg/kg) groups.
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Graph Comparing the pH of Gastric contents collected from each
Of the Control, Standard and the Extract (400 and 200mg/kg) groups
Graph No.4
Comparison of Free Acidity of the Control, Standard and the
Extract (400 and 200mg/kg) groups.
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Comparison of Total Acidity of the Control, Standard and the
Extract (400 and 200mg/kg) groups.
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ULCER IMAGES (Pylorus Ligation):
(A) (B)
(C) (D)
(A)– Control ; (B) – Standard ; (C) – Extract 400mg/kg ; (D) – Extract
200mg/kg
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HISTOPATHOLOGY IMAGES –PYLORUS LIGATED ULCERS
(A) (B)
(C) (D)
(A) – Control; (B) – Standard; (C) – Extract 400mg; (D) – Extract 200mg
Histopathology examination: The histopathological examination of stomachs
of the rats showed a better picture of the gastric lesions and the damage occured to
the stomach mucosa. Acute ulceration of stomach was observed in group-I, Group
(A) (control group rats) shows mucosal ulceration consisting of necrosis, cellular
debris, neutrophils and degenerated epithelial cells. Group-II(B) shows gastric
mucosa with intact epithelium, lamina propria and muscularis mucosa. Group (C)
shows intact mucosa with plenty of regenerative epithelial cells Group (D) shows
focal mucosal ulceration consisting of degenerated cells and also contains few
regenerated epithelial cells
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7.3.2. Anti-Inflammatory Evaluation:
Carrageenin-induced paw oedema:
The anti-inflammatory effect of ethonolic extract of Solanum pubescens
willd at the dose levels of 400mg/kg and 200mg/kg was studied in Carrageenin
induced hind paw oedema in Rats. The standard drug Indomethacin produced
significant (P<0.01) anti-inflammatory activity. The test drug ethonolic extract of
Solanum pubescens willd showed significant (P<0.01) anti-inflammatory activity
against carrageenin induced paw oedema. The activity was observed to be dose
dependant, with 400mg/kg dose showing more activity than the 200mg/kg dose but
not as much extent to that of the standard.
The maximum activity of the standard drug Indomethacin was observed at
240min. but the reduction of thickness of the paw was evident from 60mins onward.
The extracts 400mg/kg and 200mg/kg have followed a similar pattern but the
amount of diminution of the inflammation was less when compared to the standard
group.
Graph Comparing the of Paw Thickness at different time periods.
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Table No. 8
Standard: Indomethacin (10mg/kg); Alc 400: Ethanolic Extract at dose 400mg/kg; Alc 200: Ethanolic Extract at dose 400mg/kg.
Data represents the mean ± SEM (n=5). *p< 0.05, **p<0.01.
Drug
Treatment
Paw Thickness (mm)
Dose 0 min 30 min 60 min 120 min 240 min
Control 0.5% CMC 0.27 ± 0.02 0.40 ± 0.01 0.65 ± 0.01 0.48 ± 0.22 0.46 ± 0.04
Standard 10 mg/kg 0.22 ± 0.03 0.28 ± 0.02** 0.32 ± 0.03** 0.36 ± 0.01** 0.13 ± 0.03**
Alc 400 400 mg/kg 0.23 ± 0.01 0.35 ± 0.01ns 0.57± 0.01* 0.42 ± 0.02* 0.32 ± 0.02**
Alc 200 200 mg/kg 0.23 ±0.01 0.31 ±0.01* 0.41 ± 0.01** 0.39 ± 0.02** 0.30 ± 0.02**
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8. DISCUSSION
In this study, the anti-ulcer and anti-inflammatory activities of ethonolic
extract of Solanum pubescens willd has been studied. The anti-ulcer activity was
evaluated against Aspirin induced and Pylorus ligated ulcers. The anti-inflammatory
study was studied using Carrageenin induced paw oedema.
Gastric ulcer disease is an imbalance between mucosal defense factors
(bicarbonate, mucin, prostaglandin, nitric oxide, and other peptides and growth
factors) and injurious factors (acid and pepsin). Ulcer  caused by pylorus ligation is
due to increased accumulation of gastric  acid  and  pepsin  leading  to  auto
digestion  of  gastric  mucosa  and  break  down  of  the gastric mucosal barrier. The
activation of the vagus-vagal reflux by stimulation of pressure receptors in the antral
gastric  mucosa  in  the  hyper  secretion  model  of  pylorus  ligature  is believed to
increase  gastric  acid  secretion. NSAIDs are also frequently associated with peptic
ulcers Topical injury by the luminal presence of the drug appears to play a minor
role in the pathogenesis of these ulcers, as evidenced by the fact that ulcers can
occur with very low doses of aspirin (10 mg) or with parenteral administration of
NSAIDs. The effects of these drugs are instead mediated systemically; the critical
element is suppression of the constitutive form of cyclooxygenase-1 (COX-1) in the
mucosa and decreased production of the cytoprotective prostaglandin
(PGE2andPGI2).
Antiulcer  effect  is  supported  by  the  decrease  in  the  aggressive  factors
like  gastric volume,  decrease  in  free  and  total  acidity  and  an  increase  in  the
resistance  factors  like  pH showing the anti-secretary mechanism. It is significant to
note when the pH was nearing 5.2 (Std) and 3.5 (Ext 400mg/kg), the ulcer score
appeared less. The  antiulcer  agent  may  protect  the  mucosa  from  acid  effects
by selectively increasing prostaglandins. Prostaglandins have a vital protective role.
The  mucosal  defense  mechanism  may  be  due  to  the  epithelial  cells  of  the
gastric mucosa, which are impermeable to H+ ions thereby forming a physical
barrier (S.Narayan et.al.,).
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The ethonolic extract of  solanum pubescens willd was evaluated by using
aspirin induced ulcer model, Oral administration of  ethanol extract of solanum
pubescens willd at doses of 200 and 400mg/kg exhibited dose dependent inhibition
percentage of 53.26% and 63.23% (p<0.001) respectively compared to the ulcer
control, proving the anti ulcer activity. The standard drug omeprazole (20mg/kg)
exhibited percentage inhibition of 71.48% when compared with ulcer control.
Extract treated and ulcer control group was compared with normal control group.
The ethonolic extract of  solanum pubescens willd was evaluated by using
pylorus ligation method , Oral administration of  ethanol extract of solanum
pubescens willd at doses of 200 and 400mg/kg exhibited dose dependent inhibition
percentage of 36.28% and 52.3% (p<0.001) respectively compared to the ulcer
control, proving the anti ulcer activity. The standard drug omeprazole (20mg/kg)
exhibited percentage inhibition of 70% when compared with ulcer control. Extract
treated and ulcer control group was compared with normal control group.
Inflammation is the protective response of the living individual to get rid of
the cause and effect of injury (microbes, toxins, necrotic tissues). Inflammation of
prolonged duration (weeks and months), in which active inflammation, tissue
destruction and healing occur simultaneously The enzyme,  phospholipase  A2,  is
known  to  be  responsible  for the formation of mediators of inflammation such as
prostaglandins and  leukotrienes  which  by  attracting  polymer-pronuclear
leucocytes  to  the  site  of  inflammation  would lead  to  tissue  damage  probably
by  the  release  of  free radicals. Phospholipase A2 converts phospholipids in the
cell membrane into arachidonic acid, which is highly reactive and is rapidly
metabolized by cyclooxygenase (prostaglandin synthesis) to prostaglandins, which
are major components that induce pain and inflammation (Higgs et al., 1984; Vane,
1971).
Carrageenan induced rat paw edema is a suitable experimental animal model
for evaluating the anti-edematous effect of natural products. Induction of the oedema
by this model is believed to be triphasic, namely
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I. The first phase (1hr after carrageenan challenge) involves the release of
serotonin and histamine from mast cells,
II. The second phase (2hr) is provided by kinins and
III. The third phase (3hr) is mediated by prostaglandins, the cycloxygenase
products and lipoxygenase products (Sertie et al., 1990).
The metabolites of arachidonic acid formed via the cycloxygenase and
lipoxygenase pathways represent two important classes of inflammatory mediators,
prostaglandins (products of the cycloxygenase pathway) especially prostaglandin E2
is known to cause or enhance the cardinal signs of inflammation, similarly,
leukotriene B4 (product of lipoxygenase pathway) is a mediator of leukocyte
activation in the inflammatory cascade.
The present study showed that ethonolic extract of solanum pubescens willd was
evaluated by using Carrageenin-induced paw oedema.The anti-inflammatory activity
evaluated by using a parameter - reduction in paw thickness. The ethonolic extracts
and standard drug given at dose of 200,400and 10mg/kg. The ethonolic extract
200mg/kg showed reduced paw thickness (mm) was 0.23±0.01, 0.31±0.01*, 0.41±
0.01**, 0.39 ± 0.02**, 0.30 ± 0.02** at 0, 30, 60,120 and 240 mins. The ethonolic
extract 400 mg/kg showed reduction of paw thickness(mm) was 0.23 ± 0.01, 0.35
± 0.01ns, 0.57± 0.01*,0.42 ± 0.02*,0.32 ± 0.02** at 0,30,60,120,240 mins.
The standard drug showed reduced paw thickness (mm) was 0.22 ± 0.03, 0.28 ±
0.02**, 0.32 ± 0.03**, 0.36 ± 0.01**, 0.13 ± 0.03** at 0, 30, 60,120, 240 mins. The
maximum activity of the standard drug Indomethacin was observed at 240min. but
the reduction of thickness of the paw was evident from 60mins onward. The extracts
400mg/kg and 200mg/kg have showed reduced paw thickness was evident from 60
min onwards, but the amount of diminution of the inflammation was less when
compared to the standard group.
Chapter 9 Conclusion
Department of Pharmacology 81 J.K.K.Nattraja college of Pharmacy
9. CONCLUSION
The present study showed that the ethonolic extract of Solanum pubescens
willd leaves possess Anti-ulcer and Anti-inflammatory activity in animal models.
Solanum pubescens willd showed a significant decrease in the ulcer development in
both the animal models ( pylorus ligated model and Aspirin-induced ulcer model)
used in the study.
In pylorus ligation, both the doses showed significant anti-ulcer activity by
reduction in ulcer index, gastric volume, free acidity, total acidity as compared to
the control group. A similar result was observed in the aspirin induced ulcer model
too. The intensity of heamorrhage and lesions was significantly reduced upon
pretreatment with the extract, revealing the protective effect of EESP.
In the Anti-inflammatory study, Solanum pubescens willd leaves extract
showed worthy anti-inflammatory action in the Carrageenin induced Paw oedema
model in rats. Flavonoids and tannins are the major constituents that are present in
the leaves of Solanum pubescens willd which may be responsible for its Ulcer-
protective and Anti-inflammatory activity.
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